Document:

<PAGE>
                                                                   EXHIBIT 10.14

                       NOTE AND WARRANT PURCHASE AGREEMENT

                                      AMONG

                                EMAGEON UV, INC.

                                       AND

                       WHITECAP ALABAMA GROWTH FUND I, LLC
                          ENHANCED ALABAMA ISSUER, LLC
                   ADVANTAGE CAPITAL ALABAMA PARTNERS I, L.P.

                            DATED AS OF JUNE 25, 2004

<PAGE>

                                TABLE OF CONTENTS

<TABLE>
<S>                                                                                                               <C>
Article 1 PURCHASE, SALE AND TERMS OF NOTES AND WARRANTS..........................................................3

         Section 1.1       The Notes..............................................................................3
         Section 1.2       The Warrants...........................................................................3
         Section 1.3       Purchase and Sale of Notes and Warrants................................................4
         Section 1.4       Payments and Endorsements..............................................................4
         Section 1.5       Redemptions of Notes...................................................................4
(a)      Required Redemptions.....................................................................................4
(b)      Optional Redemptions.....................................................................................5
(c)      Notice of Redemptions; Pro rata Redemptions..............................................................5
         Section 1.6       Payment on Non-Business Days...........................................................5
         Section 1.7       Registration of Notes, etc.............................................................5
         Section 1.8       Transfer and Exchange of Notes.........................................................5
         Section 1.9       Replacement of Notes...................................................................6
         Section 1.10      Events of Default......................................................................6
         Section 1.11      Board Observation Rights...............................................................8

Article 2 REPRESENTATIONS AND WARRANTIES OF THE COMPANY...........................................................8

         Section 2.1       Organization, Qualifications and Corporate Power.......................................8
         Section 2.2       Authorization of Agreements, Etc.......................................................8
         Section 2.3       Validity...............................................................................9
         Section 2.4       Authorized Capital Stock...............................................................9
         Section 2.5       Financial Statements...................................................................9
         Section 2.6       Governmental Approvals................................................................10
         Section 2.7       Negative Pledge of Intellectual Property..............................................10
         Section 2.8       Offering of the Notes and Warrants....................................................10
         Section 2.9       Brokers...............................................................................10

Article 3 REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS.......................................................10

Article 4 CONDITIONS TO THE OBLIGATIONS OF THE PURCHASERS........................................................11

         Section 4.1       Conditions to the Obligations of Purchasers...........................................11
(a)      Opinion of Company's Counsel............................................................................11
(b)      Representations and Warranties to be True and Correct...................................................11
(c)      Performance.............................................................................................11
(d)      All Proceedings to be Satisfactory......................................................................11
(e)      Supporting Documents....................................................................................12
(f)      Preemptive and First Refusal Rights.....................................................................12
(g)      Oversight Entity Approvals..............................................................................12
(h)      Security Agreement......................................................................................12

Article 5 COVENANTS OF THE COMPANY...............................................................................12

         Section 5.1       Financial Statements, Reports, Etc....................................................13
</TABLE>

<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                         Page ii

<TABLE>
<S>                                                                                                              <C>
         Section 5.2       Corporate Existence...................................................................13
         Section 5.3       Properties, Business, Insurance.......................................................13
         Section 5.4       Use of Proceeds.......................................................................13
         Section 5.5       Compliance with Laws..................................................................13
         Section 5.6       Keeping of Records and Books of Account...............................................14
         Section 5.7       Tangible Net Worth....................................................................14
         Section 5.8       Debt..................................................................................14
         Section 5.9       Subordination.........................................................................14

Article 6 MISCELLANEOUS..........................................................................................15

         Section 6.1       Expenses..............................................................................15
         Section 6.2       Survival of Agreements................................................................15
         Section 6.3       Brokerage.............................................................................15
         Section 6.4       Parties in Interest...................................................................15
         Section 6.5       Notices...............................................................................15
         Section 6.6       Governing Law.........................................................................15
         Section 6.7       Entire Agreement......................................................................16
         Section 6.8       Counterparts..........................................................................16
         Section 6.9       Amendments............................................................................16
         Section 6.10      Severability..........................................................................16
         Section 6.11      Titles and Subtitles..................................................................16
         Section 6.12      Confidentiality.......................................................................16
</TABLE>

SCHEDULE I                       Schedule of Purchasers
SCHEDULE II                      Security Holders

INDEX TO EXHIBITS

EXHIBIT A                        Form of Note
EXHIBIT B                        Form of Stock Purchase Warrant
EXHIBIT C                        Charter and All Amendments Thereto
EXHIBIT D                        Form of Opinion Letter

<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                          Page 3

         NOTE AND WARRANT PURCHASE AGREEMENT, dated as of June 25, 2004, among
Emageon UV, Inc., a Delaware corporation (the "Company"), and Whitecap Alabama
Growth Fund I, LLC, an Alabama limited liability company, Enhanced Alabama
Issuer, LLC, an Alabama limited liability company, and Advantage Capital Alabama
Partners I, L.P., an Alabama limited partnership, (individually a "Purchaser"
and collectively the "Purchasers").

         WHEREAS, the Company wishes to issue and sell to the Purchasers an
aggregate of $4,000,000 in principal amount of its promissory notes, together
with stock purchase warrants exercisable for shares of common stock of the
Company; and

         WHEREAS, the Purchasers, severally, wish to purchase the notes and
warrants on the terms and subject to the conditions set forth in this Agreement;

         NOW, THEREFORE, in consideration of the premises and the mutual
covenants contained in this Agreement, the parties agree as follows:

                                   ARTICLE 1

                 PURCHASE, SALE AND TERMS OF NOTES AND WARRANTS

         SECTION 1.1 THE NOTES. The Company has authorized the issuance and sale
to the Purchasers, in the respective amounts set forth in the Schedule of
Purchasers attached as Schedule I hereto, of the Company's Promissory Notes, due
June 25, 2007, in the original aggregate principal amount of $4,000,000. The
Notes shall be substantially in the form set forth in Exhibit A hereto and are
herein referred to individually as a "Note" and collectively as the "Notes,"
which terms shall also include any notes delivered in exchange or replacement
therefor.

         SECTION 1.2 THE WARRANTS. The Company has also authorized the issuance
and sale to the Purchasers of the Company's Stock Purchase Warrants for the
issuance (subject to adjustment as provided in the Warrants) of shares of the
Company's Common Stock as set forth in the Stock Purchase Warrants. The number
of shares of Common Stock of the Company for which such Stock Purchase Warrants
in the aggregate shall be exercisable shall initially be One Million Fifty-Two
Thousand Six Hundred Thirty-Two (1,052,632), and the Stock Purchase Warrants
shall have an exercise price of $.57 per share. Additionally, (i) if the entire
principal amount of the Notes and all accrued interest has not been repaid on or
before December 25, 2005, the Stock Purchase Warrants shall be exercisable for
an additional number of shares of Common Stock which is equal to ten percent
(10%) of the remaining then-outstanding principal amount of the Notes issued
pursuant to this Agreement divided by 0.57, and (ii) if the remaining principal
amount of the Notes and all accrued interest has not been repaid on or before
June 25, 2007, the Company will be in default under this Agreement and the Stock
Purchase Warrants shall be exercisable for an additional number of shares of
Common Stock which is equal to twenty percent (20%) of the remaining
then-outstanding principal amount of the Notes issued pursuant to this Agreement
divided by $0.57. The Stock Purchase Warrants shall be substantially in the form
set forth in Exhibit B hereto (which form of Stock Purchase Warrants shall
contain such other applicable terms as set forth therein) and are herein
referred to individually as a "Warrant" and collectively as the "Warrants",
which terms shall also include any warrants delivered in exchange or replacement
therefor.
<PAGE>
                                             Note and Warrant Purchase Agreement
                                                                          Page 4

         SECTION 1.3 PURCHASE AND SALE OF NOTES AND WARRANTS. On the Closing
Date (as defined below), the Company will issue and sell to each of the
Purchasers, and, subject to and in reliance upon the representations,
warranties, terms and conditions of this Agreement, each of the Purchasers,
severally and not jointly, will purchase, Notes in the principal amount set
forth opposite each Purchaser's name under the heading "Principal Amount of
Notes" in the Schedule of Purchasers attached as Schedule I and a Warrant for
the aggregate purchase price set forth therein. The closing shall take place at
the office of Balch & Bingham LLP, 1901 Sixth Avenue North, Suite 2600,
Birmingham, Alabama, on June 25, 2004 at 3:00 P.M., central time, or at such
other location, date and time as may be mutually agreed upon among the
Purchasers and the Company (such closing being called the "Closing" and such
date and time being called the "Closing Date"). At the Closing, the Company will
issue and deliver to each Purchaser one Note, payable to the order of such
Purchaser, in the principal amount set forth opposite such Purchaser's name
under the heading "Principal Amount of Notes" in the Schedule of Purchasers
attached as Schedule I, and one Warrant, registered in the name of such
Purchaser, exercisable for shares of Common Stock of the Company as provided
therein, against (i) delivery to the Company of a check payable to the order of
the Company, in the amount set forth opposite the name of such Purchaser under
the heading "Aggregate Purchase Price for Notes and Warrants" on Schedule I,
(ii) transference of such sum to the account of the Company by wire transfer, or
(iii) delivery or transference of such sum to the Company by any combination of
such methods of payment.

         SECTION 1.4 PAYMENTS AND ENDORSEMENTS. Payments of principal and
interest on the Notes shall be made directly by check duly mailed or delivered
to the Purchasers at their addresses referred to in the Schedule of Purchasers
attached as Schedule I; provided, however, that in the case of Whitecap Alabama
Growth Fund I, LLC, and Advantage Capital Alabama Partners I, L.P., payment
shall be made directly by wire transfer to the accounts specified on Schedule I,
without any presentment or notation of payment, except that prior to any
transfer of any Note, the holder of record shall endorse on such Note a record
of the date to which interest has been paid and all payments made on account of
principal of such Note.

         SECTION 1.5 REDEMPTIONS OF NOTES.

                  (a) REQUIRED REDEMPTIONS. Starting July 25, 2005 through June
         25, 2007, the Company will pay to the Purchasers in eight (8)
         installments and on a quarterly basis $300,000 of the principal amount
         of the Notes. These eight (8) quarterly principal payments are due as
         of the first day of each respective quarter, beginning on June 25,
         2005. On the earlier of: (i) June 25, 2007, (ii) the accelerated
         maturity of the Notes in accordance with the provisions of the Notes,
         or (iii) the occurrence of a Redemption Event, the Company will pay the
         principal amount of the Notes then outstanding together with all
         accrued and unpaid interest then due thereon. A Redemption Event shall
         mean (1) any Change of Control of the Company, (2) the issuance of any
         other debt by the Company that is prohibited by section 5.8 of this
         Agreement, or (3) the refinancing of the Silicon Valley Bank line of
         credit (for purposes of this subsection (4), "refinancing" shall not
         include periodic renewals or extensions of the line of credit by
         Silicon Valley Bank). A "Change of Control of the Company" shall be
         deemed to have occurred if (a) any "person" (as such term is used in
         Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as
         amended (the "Exchange Act") becomes the "beneficial owner" (as defined
         in

<PAGE>
                                             Note and Warrant Purchase Agreement
                                                                          Page 5

         Rule 13d-3 promulgated under the Exchange Act), directly or indirectly,
         of securities of the Company representing 50% or more of (A) the
         outstanding shares of common stock of the Company or (B) the combined
         voting power of the Company's then outstanding securities; (b) the
         Company is party to a merger or consolidation that results in the
         voting securities of the Company outstanding immediately prior thereto
         failing to continue to represent (either by remaining outstanding or by
         being converted into voting securities of the surviving or another
         entity) at least fifty (50%) percent of the combined voting power of
         the voting securities of the Company or such surviving or other entity
         outstanding immediately after such merger or consolidation; or (c) the
         sale or disposition of all or substantially all of the Company's assets
         (or consummation of any transaction having similar effect).

                  (b) OPTIONAL REDEMPTIONS. The Notes may be prepaid at any time
         without a premium or penalty.

                  (c) NOTICE OF REDEMPTIONS; PRO RATA REDEMPTIONS. Each
         redemption of Notes shall be made to the holders of the Notes in the
         same ratio as the total principal amount of Notes then held by such
         holder bears to the aggregate principal amount of the Notes then
         outstanding.

         SECTION 1.6 PAYMENT ON NON-BUSINESS DAYS. Whenever any payment to be
made shall be due on a Saturday, Sunday or a public holiday under the laws of
the State of Alabama, such payment may be made on the next succeeding business
day, and such extension of time shall in such case be included in the
computation of payment of interest due.

         SECTION 1.7 REGISTRATION OF NOTES, ETC. The Company shall maintain at
its principal office a register of the Notes and shall record therein the names
and addresses of the registered holders of the Notes, the address to which
notices are to be sent and the address to which payments are to be made as
designated by the registered holder if other than the address of the holder, and
the particulars of all transfers, exchanges and replacements of Notes. No
transfer of a Note shall be valid unless made on such register for the
registered holder or his executors or administrators or his or their duly
appointed attorney, upon surrender therefor for exchange as hereinafter
provided, accompanied by an instrument in writing, in form and execution
reasonably satisfactory to the Company. Each Note issued hereunder, whether
originally or upon transfer, exchange or replacement of a Note or Notes, shall
be registered on the date of execution thereof by the Company and shall be dated
the date to which interest has been paid on such Notes or Note. The registered
holder of a Note shall be that person in whose name the Note has been so
registered by the Company. A registered holder shall be deemed the owner of a
Note for all purposes of this Agreement and, subject to the provisions hereof,
shall be entitled to the principal and interest evidenced by such Note free from
all equities or rights of setoff or counterclaim between the Company and the
transferor of such registered holder or any previous registered holder of such
Note.

         SECTION 1.8 TRANSFER AND EXCHANGE OF NOTES. The registered holder of
any Note or Notes may, prior to maturity, surrender such Note or Notes at the
principal office of the Company for transfer or exchange. Within a reasonable
time after notice to the Company from a registered holder of its intention to
make such exchange and without expense (other than transfer

<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                          Page 6

taxes, if any) to such registered holder, the Company shall, upon the consent of
sixty percent (60%) or more of the Company's then-existing preferred
stockholders (unless an Event of Default shall have occurred and be continuing,
in which case no preferred stockholder consent shall be required), issue in
exchange therefor another Note or Notes, in such denominations as requested by
the registered holder, for the same aggregate principal amount as the unpaid
principal amount of the Note or Notes so surrendered and having the same
maturity and rate of interest, containing the same provisions and subject to the
same terms and conditions as the Note or Notes so surrendered. Each new Note
shall be made payable to such person or persons, or registered assigns, as the
registered holder of such surrendered Note or Notes may designate, and such
transfer or exchange shall be made in such a manner that no gain or loss of
principal or interest shall result therefrom.

         SECTION 1.9 REPLACEMENT OF NOTES. Upon receipt of evidence satisfactory
to the Company of the loss, theft, destruction or mutilation of any Note and, if
requested in the case of any such loss, theft or destruction, upon delivery of
an indemnity bond or other agreement or security reasonably satisfactory to the
Company, or, in the case of any such mutilation, upon surrender and cancellation
of such Note, the Company will issue a new Note, of like tenor and amount and
dated the date to which interest has been paid, in lieu of such lost, stolen,
destroyed or mutilated Note; provided, however, if any Note of which a Purchaser
whose name is set forth in the Schedule of Purchasers attached as Schedule I,
its nominee, or any of its partners is the registered holder is lost, stolen or
destroyed, the affidavit of the Chief Executive Officer, Treasurer or any
Assistant Treasurer or any other authorized representative of the registered
holder setting forth the circumstances with respect to such loss, theft or
destruction shall be accepted as satisfactory evidence thereof, and no
indemnification bond or other security shall be required as a condition to the
execution and delivery by the Company of a new Note in replacement of such lost,
stolen or destroyed Note other than the registered holder's written agreement to
indemnify the Company.

         SECTION 1.10 EVENTS OF DEFAULT. If any of the following events ("Events
of Default") shall occur and be continuing:

                  (a)      The Company shall fail to pay any installment of
                           principal or interest of any of the Notes when due
                           and such failure remains unremedied for five (5)
                           days; or

                  (b)      Any material representation or warranty made by the
                           Company in this Agreement, or by the Company (or any
                           officers of the Company) in any certificate or
                           instrument contemplated by or made or delivered
                           pursuant to or in connection with this Agreement
                           shall prove to have been incorrect when made in any
                           material respect; or

                  (c)      The Company shall fail to perform or observe any
                           other material term, covenant or agreement contained
                           in this Agreement, the Notes or the Warrants, or any
                           agreement executed and delivered by the Company in
                           connection with this Agreement on its part to be
                           performed or observed and any such failure remains
                           unremedied for thirty (30) days after written notice
                           thereof shall have been given to the Company by any
                           registered holder of the Notes; or
<PAGE>
                                             Note and Warrant Purchase Agreement
                                                                          Page 7

                  (d)      The Company shall be in default under that certain
                           Loan and Security Agreement between the Company and
                           Silicon Valley Bank dated April 30, 2004, and such
                           default remains unremedied for five (5) days; or

                  (e)      The Company shall be involved in financial
                           difficulties as evidenced (i) by its admitting in
                           writing its inability to pay its debts generally as
                           they become due; (ii) by its commencement of a
                           voluntary case under Title 11 of the United States
                           Code as from time to time in effect, or by its
                           authorizing, by appropriate proceedings of its Board
                           of Directors or other governing body, the
                           commencement of such a voluntary case which is not
                           dismissed within sixty (60) days; (iii) by its filing
                           an answer or other pleading admitting or failing to
                           deny the material allegations of a petition filed
                           against it commencing an involuntary case under said
                           Title 11, or seeking, consenting to or acquiescing in
                           the relief therein provided, or by its failing to
                           controvert timely the material allegations of any
                           such petition; (iv) by the entry of an order for
                           relief in any involuntary case commenced under said
                           Title 11; (v) by its seeking relief as a debtor under
                           any applicable law, other than said Title 11, of any
                           jurisdiction relating to the liquidation or
                           reorganization of debtors or to the modification or
                           alteration of the rights of creditors, or by its
                           consenting to or acquiescing in such relief; (vi) by
                           the entry of an order by a court of competent
                           jurisdiction (a) finding it to be bankrupt or
                           insolvent, (b) ordering or approving its liquidation,
                           reorganization or any modification or alteration of
                           the rights of its creditors, or (c) assuming custody
                           of, or appointing a receiver or other custodian for,
                           all or a substantial part of its property; or (vii)
                           by its making an assignment for the benefit of, or
                           entering into a composition with, its creditors, or
                           appointing or consenting to the appointment of a
                           receiver or other custodian for all or a substantial
                           part of its property; or

                  (f)      Any judgment, writ, warrant of attachment or
                           execution or similar process shall be issued or
                           levied against a substantial part of the property of
                           the Company and such judgment, writ, or similar
                           process shall not be released, vacated or fully
                           bonded within sixty (60) days after its issue or
                           levy; or

                  (g)      Revocation of the Company's status as a Qualified
                           Technology Business (as that term is defined in
                           Alabama Code Section 40-14B-1, et. seq., and the
                           regulations promulgated by the Alabama Development
                           Office thereunder, together, hereinafter referred to
                           as the "Alabama CAPCo Law") by the Alabama
                           Development Office; or

                  (h)      Material violation by the Company of one or more
                           provisions of the Alabama CAPCo Law;

then, and in any such event, any holder of any Note may, by notice to the
Company, declare the entire unpaid principal amount of the Notes, all interest
accrued and unpaid thereon and all other amounts payable under this Agreement to
be forthwith due and payable, whereupon the Notes, all such accrued interest and
all such amounts shall become and be forthwith due and payable (unless there
shall have occurred an Event of Default under subsection 1.10(f) in which case
all

<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                          Page 8

such amounts shall automatically become due and payable), without presentment,
demand, protest or further notice of any kind, all of which are hereby expressly
waived by the Company.

         SECTION 1.11 BOARD OBSERVATION RIGHTS. The Purchasers, by unanimous
vote, shall have the right to appoint one board observer to the Board of
Directors of the Company, who shall initially be representative of the
non-affiliate investors, who (i) shall have observation rights at all Company
Board of Directors meetings, (ii) will have the right to receive any
communications to Company Directors, and (iii) will be reimbursed by the Company
for all reasonable out-of-pocket travel and lodging expenses incurred to attend
such meetings. The Purchasers' initial board observer shall be Lawrence W. Greer
("Greer"). In the event that Greer becomes unwilling or unable to serve in such
capacity, the Purchasers shall have the right to appoint his successor upon such
terms and conditions as the Purchasers deem appropriate.

                                   ARTICLE 2
                  REPRESENTATIONS AND WARRANTIES OF THE COMPANY

                  The Company represents and warrants to the Purchasers that, as
                  of each Closing:

         SECTION 2.1 ORGANIZATION, QUALIFICATIONS AND CORPORATE POWER.

                  (a)      The Company is a corporation duly incorporated,
                           validly existing and in good standing under the laws
                           of the State of Delaware and is duly licensed or
                           qualified to transact business as a foreign
                           corporation and is in good standing in each
                           jurisdiction in which the nature of the business
                           transacted by it or the character of the properties
                           owned or leased by it requires such licensing or
                           qualification, except where the failure to be so
                           licensed or qualified does not have a material
                           adverse effect on the Company's business or financial
                           condition. The Company has the corporate power and
                           authority to own and hold its properties and to carry
                           on its business as now conducted and as proposed to
                           be conducted, to execute, deliver and perform this
                           Agreement, to issue, sell and deliver the Notes and
                           Warrants and to issue and deliver the shares of
                           Common Stock of the Company upon exercise of the
                           Warrants (the "Warrant Shares").

                  (b)      The Company has one wholly-owned subsidiary. Other
                           than such subsidiary, the Company does not (i) own of
                           record or beneficially, directly or indirectly, (A)
                           any shares of capital stock or securities convertible
                           into capital stock of any other corporation or (B)
                           any participating interest in any partnership, joint
                           venture or other non-corporate business enterprise or
                           (ii) control, directly or indirectly, any other
                           entity.

         SECTION 2.2 AUTHORIZATION OF AGREEMENTS, ETC.

                  (c)      The execution and delivery by the Company of this
                           Agreement, the performance by the Company of its
                           obligations hereunder, the issuance, sale and
                           delivery of the Notes and Warrants have been duly
                           authorized by all requisite corporate

<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                          Page 9

                           action and will not violate any provision of law, any
                           order of any court or other agency of government, the
                           Certificate of Incorporation (the "Charter") or the
                           By-laws of the Company, as amended, or any provision
                           of any indenture, contract, agreement or other
                           instrument to which the Company or any of its
                           properties or assets is bound (including, without
                           limitation, that certain line of credit agreement
                           between the Company and Silicon Valley Bank), or
                           conflict with, result in a breach of or constitute
                           (with due notice or lapse of time or both) a default
                           under any such indenture, contract, agreement or
                           other instrument, or result in the creation or
                           imposition of any lien, charge, restriction, claim or
                           encumbrance of any nature whatsoever upon any of the
                           properties or assets of the Company.

                  (d)      The Notes and Warrants have been duly authorized and,
                           when issued in accordance with this Agreement, will
                           be free and clear of all liens, charges,
                           restrictions, claims and encumbrances imposed by or
                           through the Company. The shares of Common Stock of
                           the Company issuable upon exercise of the Warrants
                           will be duly reserved for issuance upon exercise of
                           the Warrants and, when so issued, will be duly
                           authorized, validly issued, fully paid and
                           nonassessable shares of Common Stock, and will be
                           free and clear of all liens, charges, restrictions,
                           claims and encumbrances imposed by or through the
                           Company, except for transfer restrictions imposed by
                           applicable securities laws. The issuance, sale or
                           delivery of the Notes and Warrants, or the issuance
                           or delivery of the Warrant Shares is not subject to
                           any preemptive right of shareholders of the Company
                           or to any right of first refusal or other right in
                           favor of any person.

         SECTION 2.3 VALIDITY. This Agreement, the Notes and the Warrants have
been duly executed and delivered by the Company and constitutes the legal, valid
and binding obligation of the Company, enforceable in accordance with its terms
(subject, as to enforcement of remedies, to the discretion of courts in awarding
equitable relief and to applicable bankruptcy, reorganization, insolvency,
moratorium and similar laws affecting the rights of creditors generally).

         SECTION 2.4 AUTHORIZED CAPITAL STOCK. The authorized capital stock of
the Company consists of [capital structure to be provided by Emageon in the form
as provided in Schedule II]

         SECTION 2.5 FINANCIAL STATEMENTS. The Company has furnished to the
Purchasers the audited balance sheet of the Company as of December 31, 2003 (the
"Balance Sheet") and the related audited statements of operations, stockholders'
equity and cash flows of the Company for the year ended December 31, 2003. All
such financial statements have been prepared in accordance with generally
accepted accounting principles consistently applied and fairly present the
financial position of the Company as of December 31, 2003, and the results of
its operations and cash flows for the year ended December 31, 2003. Since the
date of the Balance Sheet, (i) there has been no change in the assets,
liabilities or financial condition of the Company from that reflected in the
Balance Sheet except for changes in the ordinary course of business which in the
aggregate have not been materially adverse and (ii) none of the business,
prospects, financial condition, operations, property or affairs of the Company
has been materially adversely affected by any occurrence or development,
individually or in the aggregate, whether or not insured against.

<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                         Page 10

         SECTION 2.6 GOVERNMENTAL APPROVALS. Subject to the accuracy of the
representations and warranties of the Purchasers set forth in Article III, no
registration or filing with, or consent or approval of or other action by, any
federal, state or other governmental agency or instrumentality is or will be
necessary for the valid execution, delivery and performance by the Company of
this Agreement, the issuance, sale and delivery of the Notes or Warrants or,
upon exercise thereof, the issuance and delivery of the Warrant Shares, other
than (i) filings pursuant to state securities laws (all of which filings have
been made by the Company, other than those which are required to be made after
the Closing and which will be duly made on a timely basis) in connection with
the sale of the Notes and Warrants.

         SECTION 2.7 [INTENTIONALLY OMITTED.]

         SECTION 2.8 OFFERING OF THE NOTES AND WARRANTS. Neither the Company nor
any person authorized or employed by the Company as agent, broker, dealer or
otherwise in connection with the offering or sale of the Notes and Warrants or
any security of the Company similar to the Notes and Warrants has offered the
Notes and Warrants or any such similar security for sale to, or solicited any
offer to buy the Notes and Warrants or any such similar security from, or
otherwise approached or negotiated with respect thereto with, any person or
persons, and neither the Company nor any person acting on its behalf has taken
or will take any other action (including, without limitation, any offer,
issuance or sale of any security of the Company under circumstances which might
require the integration of such security with Notes and Warrants under the
Securities Act of 1933, as amended (the "Securities Act") or the rules and
regulations of the Commission thereunder), in either case so as to subject the
offering, issuance or sale of the Notes and Warrants to the registration
provisions of the Securities Act.

         SECTION 2.9 BROKERS. The Company has no contract, arrangement or
understanding with any broker, finder or similar agent with respect to the
transactions contemplated by this Agreement.

                                   ARTICLE 3
                REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS

         Each Purchaser severally represents and warrants to the Company that:

         (a)      it is an "accredited investor" within the meaning of Rule 501
                  under the Securities Act and was not organized for the
                  specific purpose of acquiring the Notes or Warrants;

         (b)      it has sufficient knowledge and experience in investing in
                  companies similar to the Company in terms of the Company's
                  stage of development so as to be able to evaluate the risks
                  and merits of its investment in the Company and it is able
                  financially to bear the risks thereof;

         (e)      it has had an opportunity to discuss the Company's business,
                  management and financial affairs with the Company's
                  management;

<PAGE>
                                             Note and Warrant Purchase Agreement
                                                                         Page 11

         (f)      the Notes and Warrants being purchased by it are being
                  acquired for its own account for the purpose of investment and
                  not with a view to or for sale in connection with any
                  distribution thereof; and

         (e)      it understands that (i) the Notes and Warrants and the Warrant
                  Shares have not been registered under the Securities Act by
                  reason of their issuance in a transaction exempt from the
                  registration requirements of the Securities Act pursuant to
                  Section 4(2) thereof or Rule 505 or 506 promulgated under the
                  Securities Act, (ii) the Notes and Warrants and, upon
                  conversion thereof, the Warrant Shares must be held
                  indefinitely unless a subsequent disposition thereof is
                  registered under the Securities Act or is exempt from such
                  registration, (iii) the Notes and Warrants and the Warrant
                  Shares will bear a legend to such effect and (iv) the Company
                  will make a notation on its transfer books to such effect.

                                   ARTICLE 4
                 CONDITIONS TO THE OBLIGATIONS OF THE PURCHASERS

         SECTION 4.1 CONDITIONS TO THE OBLIGATIONS OF PURCHASERS. The obligation
of each Purchaser to purchase and pay for the Notes and Warrants being purchased
by it on the Closing Date is, at its option, subject to the satisfaction, on or
before the Closing Date of the following conditions:

                  (A) [INTENTIONALLY OMITTED.]

                  (B) REPRESENTATIONS AND WARRANTIES TO BE TRUE AND CORRECT. The
         representations and warranties contained in Article II shall be true,
         complete and correct on and as of the Closing Date with the same effect
         as though such representations and warranties had been made on and as
         of such date, and the Chief Executive Officer and Chief Financial
         Officer of the Company shall have certified to such effect to the
         Purchasers in writing.

                  (C) PERFORMANCE. The Company shall have performed and complied
         with all agreements contained herein required to be performed or
         complied with by it prior to or at the Closing Date and the Chief
         Executive Officer and Chief Financial Officer of the Company shall have
         certified to the Purchasers in writing to such effect and to the
         further effect that all of the conditions set forth in this Article IV
         have been satisfied.

                  (D) ALL PROCEEDINGS TO BE SATISFACTORY. All corporate and
         other proceedings to be taken by the Company in connection with the
         transactions contemplated hereby and all documents incident thereto
         shall be satisfactory in form and substance to the Purchasers and their
         counsel, and the Purchasers and their counsel shall have received all
         such counterpart originals or certified or other copies of such
         documents as they reasonably may request.
<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                         Page 12

                  (E) SUPPORTING DOCUMENTS. The Purchasers and their counsel
         shall have received copies of the following documents:

                  (i)      (A) the Charter, certified as of a recent date by the
                           Secretary of State of the State of Delaware, and (B)
                           a certificate of said Secretary dated as of a recent
                           date as to the due incorporation and good standing of
                           the Company, the payment of all excise taxes by the
                           Company and listing all documents of the Company on
                           file with said Secretary;

                  (ii)     a certificate of the Secretary or an Assistant
                           Secretary of the Company dated the Closing and
                           certifying: (A) that attached thereto is a true and
                           complete copy of the By-laws of the Company as in
                           effect on the date of such certification; (B) that
                           attached thereto is a true and complete copy of all
                           resolutions adopted by the Board of Directors or the
                           shareholders of the Company authorizing the
                           execution, delivery and performance of this
                           Agreement, the issuance, sale and delivery of the
                           Notes and Warrants and the reservation, issuance and
                           delivery of the Warrant Shares, and that all such
                           resolutions are in full force and effect and are all
                           the resolutions adopted in connection with the
                           transactions contemplated by this Agreement; (C) that
                           the Charter has not been amended since the date of
                           the last amendment referred to in the certificate
                           delivered pursuant to clause (i)(B) above; and (D) to
                           the incumbency and specimen signature of each officer
                           of the Company executing any of this Agreement, the
                           Notes and Warrants and any certificate or instrument
                           furnished pursuant hereto, and a certification by
                           another officer of the Company as to the incumbency
                           and signature of the officer signing the certificate
                           referred to in this clause (ii); and

                  (iii)    such additional supporting documents and other
                           information with respect to the operations and
                           affairs of the Company as the Purchasers or their
                           counsel reasonably may request.

                  (F) PREEMPTIVE AND FIRST REFUSAL RIGHTS. All shareholders of
         the Company having any preemptive or first refusal rights with respect
         to the issuance of the Notes and Warrants or the Warrant Shares shall
         have irrevocably waived the same in writing.

                  (G) SECURITY AGREEMENT. The execution and delivery by the
         Company of the Security Agreement among the Company and the Purchasers
         dated as of the Closing Date (the "Security Agreement") granting the
         Purchasers a security interest in all of the Company's assets, now
         existing or hereafter acquired (excluding equipment and intellectual
         property).

                                   ARTICLE 5
                            COVENANTS OF THE COMPANY

         The Company covenants and agrees with each of the Purchasers that:
<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                         Page 13

         SECTION 5.1 FINANCIAL STATEMENTS, REPORTS, ETC. So long as the Notes
are outstanding, the Company shall furnish to each Purchaser:

         (a)      within one hundred twenty (120) days after the end of each
                  fiscal year of the Company a consolidated balance sheet of the
                  Company and its subsidiaries, if any, as of the end of such
                  fiscal year and the related consolidated statements of
                  operations, stockholders equity and cash flows for the fiscal
                  year then ended, prepared in accordance with generally
                  accepted accounting principles and audited by a firm of
                  independent certified public accountants of recognized
                  national standing selected by the Board of Directors of the
                  Company;

         (b)      within thirty (30) days after the end of each month in each
                  fiscal year a consolidated balance sheet of the Company and
                  its subsidiaries, if any, and the related consolidated
                  statements of operations unaudited but prepared in accordance
                  with generally accepted accounting principles and certified by
                  the Chief Financial Officer of the Company, such consolidated
                  balance sheet to be as of the end of such month and such
                  consolidated statements of operations to be for such month and
                  for the period from the beginning of the fiscal year to the
                  end of such month;

         (c)      promptly after the commencement thereof, notice of all legal
                  actions, suits, claims, proceedings, investigations and/or
                  inquiries that could materially adversely affect the Company
                  or any of its subsidiaries, if any;

         (d)      promptly upon sending, making available or filing the same,
                  all press releases, reports and financial statements that the
                  Company sends or makes available to its shareholders or
                  directors or files with the Securities and Exchange
                  Commission; and

         (e)      promptly, from time to time, such other information regarding
                  the business, prospects, financial condition, operations,
                  property or affairs of the Company and its subsidiaries as
                  such Purchaser reasonably may request.

         SECTION 5.2 CORPORATE EXISTENCE. The Company shall maintain its
corporate existence, rights and franchises in full force and effect.

         SECTION 5.3 PROPERTIES, BUSINESS, INSURANCE. The Company shall maintain
as to its properties and business, with financially sound and reputable
insurers, insurance against such casualties and contingencies and of such types
and in such amounts as is customary for companies similarly situated, which
insurance shall be deemed by the Company to be sufficient.

         SECTION 5.4 USE OF PROCEEDS. The Company shall use the proceeds from
the sale of the Notes and Warrants solely for general corporate purposes.

         SECTION 5.5 COMPLIANCE WITH LAWS. The Company shall comply with all
applicable laws, rules, regulations and orders, noncompliance with which could
materially adversely affect its business or condition, financial or otherwise.
<PAGE>
                                             Note and Warrant Purchase Agreement
                                                                         Page 14

         SECTION 5.6 KEEPING OF RECORDS AND BOOKS OF ACCOUNT. The Company shall
keep adequate records and books of account, in which complete entries will be
made in accordance with generally accepted accounting principles consistently
applied, reflecting all financial transactions of the Company, and in which, for
each fiscal year, all proper reserves for depreciation, depletion, obsolescence,
amortization, taxes, bad debts and other purposes in connection with its
business shall be made.

         SECTION 5.7 TANGIBLE NET WORTH. The Company will maintain at all times
a Tangible Net Worth in the amount not less than that required by Silicon Valley
Bank in the Company's agreements with Silicon Valley Bank. Tangible Net Worth
shall mean with respect to the Company at any time, (i) the assets of the
Company including all items which should be classified as assets on the
financial statements of the Company, but excluding the amount of goodwill,
patents, trademarks, service marks, trade names, copyright and organization
expenses (to the extent reflected in determining the assets of the Company) less
(ii) all items which should be classified as liabilities on the financial
statements of the Company.

         SECTION 5.8 DEBT. Without the prior written unanimous consent of the
Purchasers, the Company shall not create, incur, assume or suffer to exist
indebtedness of any description whatsoever, excluding:

         (a)      the indebtedness evidenced by the Notes;

         (b)      the indebtedness evidenced by that certain Loan and Security
                  Agreement between the Company and Silicon Valley Bank dated
                  April 30, 2004;

         (c)      the endorsement of negotiable instruments payable to Company
                  for deposit or collection in the ordinary course of business;

         (d)      trade payables incurred in the ordinary course of business;
                  and

         (e)      indebtedness incurred in connection with equipment financings,
                  leases, and technology licenses.

         SECTION 5.9 SUBORDINATION. The Company shall not make any payment upon
any debt owing to any shareholder, insider or officer except as expressly
permitted by a subordination agreement executed by such creditor and Purchasers.

         SECTION 5.10 NEGATIVE PLEDGE OF INTELLECTUAL PROPERTY. The Company will
not pledge, mortgage, grant or permit the creation of any lien or any kind upon
the Company's intellectual property without the Purchasers' prior written
consent; provided, however, that nothing in this paragraph shall prevent Company
from granting licenses of its intellectual property in the ordinary course of
its business.

<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                         Page 15

                                   ARTICLE 6

                                 MISCELLANEOUS

         SECTION 6.1 EXPENSES. The Company will pay the first $20,000 of the
Purchaser's closing costs relating to the Notes and Warrants. Such closing costs
are due and payable to the Purchasers, out of funds other than proceeds from the
issuance and sale of the Notes, as of the Closing Date and shall be allocated
among the Purchasers in the same ratio as the total principal amount of Notes
set forth opposite each Purchaser's name under the heading "Principal Amount of
Notes" in the Schedule of Purchasers attached as Schedule I to the original
aggregate principal amount of the Notes ($4,000,000). Otherwise, each party
hereto will pay its own expenses in connection with the transactions
contemplated hereby, whether or not such transactions shall be consummated.

         SECTION 6.2 SURVIVAL OF AGREEMENTS. All covenants, agreements,
representations and warranties made in this Agreement or any certificate or
instrument delivered to the Purchasers pursuant to or in connection with this
Agreement shall survive the execution and delivery of this Agreement, the
issuance, sale and delivery of the Notes and Warrants, and the issuance and
delivery of the Warrant Shares.

         SECTION 6.3 BROKERAGE. Each party hereto will indemnify and hold
harmless the others against and in respect of any claim for brokerage or other
commissions relative to this Agreement or to the transactions contemplated
hereby, based in any way on agreements, arrangements or understandings made or
claimed to have been made by such party with any third party.

         SECTION 6.4 PARTIES IN INTEREST. All representations, covenants and
agreements contained in this Agreement by or on behalf of any of the parties
hereto shall bind and inure to the benefit of the respective successors and
assigns of the parties hereto whether so expressed or not. Without limiting the
generality of the foregoing, all representations, covenants and agreements
benefiting the Purchasers shall inure to the benefit of any and all subsequent
holders from time to time of Notes, Warrants or Warrant Shares.

         SECTION 6.5 NOTICES. All notices, requests, consents and other
communications hereunder shall be in writing and shall be delivered in person,
mailed by certified or registered mail, return receipt requested, or sent by
facsimile or recognized overnight courier service, addressed as follows:

         (g)      if to the Company, at 1200 Corporate Drive, Suite 400,
                  Birmingham, AL 35242; and

         (h)      if to any Purchaser, at the address of such Purchaser set
                  forth in Schedule I;

or, in any such case, at such other address or addresses as shall have been
furnished in writing by such party to the others.

         SECTION 6.6 GOVERNING LAW. This Agreement shall be governed by and
construed in accordance with the substantive laws of the State of Alabama.

<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                         Page 16

         SECTION 6.7 ENTIRE AGREEMENT. This Agreement, including the Schedules
and Exhibits hereto, constitutes the sole and entire agreement of the parties
with respect to the subject matter hereof. All Schedules and Exhibits hereto are
hereby incorporated herein by reference. There are no other agreements of the
parties and no party is relying on any representations of the other not
expressly set forth herein. All Schedules and Exhibits hereby are hereby
incorporated herein by reference.

         SECTION 6.8 COUNTERPARTS. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

         SECTION 6.9 AMENDMENTS. This Agreement may not be amended or modified,
and no provisions hereof may be waived, without the written consent of the
Company and the holders of at least 66-2/3% of the outstanding principal amount
of the Notes.

         SECTION 6.10 SEVERABILITY. If any provision of this Agreement shall be
declared void or unenforceable by any judicial or administrative authority, the
validity of any other provision and of the entire Agreement shall not be
affected thereby.

         SECTION 6.11 TITLES AND SUBTITLES. The titles and subtitles used in
this Agreement are for convenience only and are not to be considered in
construing or interpreting any term or provision of this Agreement.

         SECTION 6.12 CONFIDENTIALITY. The Company and each of the Purchasers
agrees to maintain the confidentiality of the Information (as defined below),
except that Information may be disclosed (a) to its and its affiliates'
directors, officers, employees and agents, including accountants, legal counsel
and other advisors (it being understood that the Persons to whom such disclosure
is made will be informed of the confidential nature of such Information and
instructed to keep such Information confidential), (b) to the extent requested
by any regulatory authority, (c) to the extent required by applicable laws or
regulations or by any subpoena or similar legal process, (d) to any other party
to this Agreement, (e) in connection with the exercise of any remedies hereunder
or under any suit, action or proceeding relating to the Agreement or the
enforcement of rights hereunder, (f) subject to an agreement containing
provisions substantially the same as those of this Section, to (i) any assignee
of, or any prospective assignee of, any of its rights or obligations under this
Agreement, (g) with the consent of the Company and unanimous consent of
Purchasers or (h) to the extent such Information (i) becomes publicly available
other than as a result of a breach of this Section or (ii) becomes available to
the Company or any Purchaser on a non-confidential basis from a source other
than the Company. For the purposes of this Section, "Information" means all
information received from the Company relating to the Company or its business,
other than any such information that is available to the Company or any
Purchaser on a non-confidential basis prior to disclosure by the Company;
provided that, in the case of information received from the Company after the
date hereof, such information is clearly identified at the time of delivery as
confidential. Any party required to maintain the confidentiality of Information
as provided in this Section shall be considered to have complied with its
obligation to do so if such party has exercised the same degree of care to
maintain the confidentiality of such Information as such party would accord to
its own confidential information.

<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                         Page 17

         IN WITNESS WHEREOF, the Company and the Purchasers have executed this
Note and Warrant Purchase Agreement as of the day and year first above written.

                                     EMAGEON UV, INC.

                                     By:
                                        ----------------------------------------
                                              Its:
                                                   -----------------------------

PURCHASERS:

WHITECAP ALABAMA GROWTH FUND I, LLC

By:
   --------------------------------
     Peter Huff, its President

ENHANCED ALABAMA ISSUER, LLC

By:
   --------------------------------
     Its:
          -------------------------

ADVANTAGE CAPITAL ALABAMA PARTNERS I, L.P.

By:
   --------------------------------
     Its:
          -------------------------

<PAGE>

                                             Note and Warrant Purchase Agreement
                                                                         Page 18

                                   SCHEDULE I
                             SCHEDULE OF PURCHASERS

INITIAL CLOSING:

<TABLE>
<CAPTION>
                                                                                          AGGREGATE PURCHASE PRICE
             NAME AND                                         PRINCIPAL AMOUNT                    FOR NOTES
       ADDRESS OF PURCHASER                                       OF NOTES                      AND WARRANTS
       --------------------                                   ----------------            ------------------------
<S>                                                           <C>                         <C>
Whitecap Alabama Growth Fund I, LLC                               $2,000,000                      $2,000,000
2200 Woodcrest Place, Suite 309
Birmingham, AL 35209

Wire Instructions:

Bank Name: US Bank
ABA #: 091000022
Account Name: US Bank Trust
Account #: 180121167365
FFC: 744845000
Attn. Todd Andersen/651-495-3767
>
Enhanced Alabama Issuer, LLC                                      $1,000,000                      $1,000,000
500 Beacon Parkway West
Birmingham, AL 35209

Advantage Capital Alabama Partners I, L.P.                        $1,000,000                      $1,000,000
207 East Side Square
Huntsville, AL 35801

Wire Instructions:

JPMorgan Chase Bank
Houston, Texas
ABA #:  113000609
A/C #:  00103409232
Account Name:  Structured #1 Trust Clearing Account
Ref:  Advantage Capital Alabama Partners I Limited
Partnership
FFC:  10207078.2
Attn:  Bill Marshall 9CTH

 TOTAL:                                                           $4,000,000                      $4,000,000
</TABLE>

<PAGE>
                                             Note and Warrant Purchase Agreement
                                                                         Page 19

                                   SCHEDULE II
                                SECURITY HOLDERS

<PAGE>

                                    EXHIBIT A

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY
STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS
IT HAS BEEN REGISTERED UNDER SUCH ACT AND ALL SUCH APPLICABLE LAWS OR THE
TRANSFEROR THEREOF HAS PROVIDED TO THE ISSUER AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO THE COMPANY, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO
THE COMPANY, TO THE EFFECT THAT AN EXEMPTION FROM REGISTRATION IS AVAILABLE.

--------------------------------------------------------------------------------

THIS NOTE IS SUBORDINATE TO THE COMPANY'S DEBT TO SILICON VALLEY BANK AND IS
SUBJECT TO THAT CERTAIN SUBORDINATION AGREEMENT EXECUTED BY THE PAYEE AND
SILICON VALLEY BANK CONTEMPORANEOUSLY HEREWITH.

                                EMAGEON UV, INC.

                             NOTE DUE JUNE 25, 2007

$                                                                  June 25, 2004
 --------

For value received, EMAGEON UV, INC., a Delaware corporation (the "Company"),
hereby promises to pay to____________________________________ or registered
assigns (hereinafter referred to as the "Payee"), on or before June 25, 2007,
the principal sum of____________________________ ($____________________) or such
part thereof as then remains unpaid, and to pay interest from the date hereof on
the whole amount of said principal sum remaining from time to time unpaid at the
rate of eight and one quarter percent (8.25%) per annum through June 25, 2006,
and at the rate of ten percent (10%) per annum beginning June 26, 2006 until the
whole amount of the principal hereof remaining unpaid shall become due and
payable, and to pay interest at the rate of twelve and one-half percent (12.5%)
per annum (so far as the same may be legally enforceable) on all overdue
principal (including any overdue required redemption), premium and interest.
Principal and interest shall be payable in lawful money of the United States of
America, in immediately available funds, at the principal office of the Payee or
at such other place as the legal holder may designate from time to time in
writing to the Company. Payments of principal and interest shall be made
according to the amortization schedule attached as Schedule A hereto. Interest
shall be computed on the basis of a 360-day year and a thirty (30) day month.
Notwithstanding any other provision of this Note, the holder hereof does not
intend to charge and the Company shall not be required to pay any interest or
other fees or charges in excess of the maximum permitted by applicable law; any
payments in excess of such maximum shall be refunded to the Company or credited
to reduce principal hereunder.

This Note is issued pursuant to and is entitled to the benefits of a certain
Note and Warrant Purchase Agreement, dated as of June 25, 2004, between the
Company and the Persons listed in the Schedule of Purchasers attached as
Schedule I thereto (as the same may be amended from

                                       20
<PAGE>

time to time, hereinafter referred to as the "Agreement"), and each holder of
this Note, by his acceptance hereof, agrees to be bound by the provisions of the
Agreement.

As further provided in the Agreement and subject to compliance with the state
and federal securities laws, upon surrender of this Note for transfer or
exchange, a new Note or new Notes of the same tenor dated the date to which
interest has been paid on the surrendered Note and in an aggregate principal
amount equal to the unpaid principal amount of the Note so surrendered will be
issued to, and registered in the name of, the transferee or transferees. The
Company may treat the person in whose name this Note is registered as the owner
hereof for the purpose of receiving payment and for all other purposes.

In case any payment herein provided for shall not be paid when due, the Company
promises to pay all cost of collection, including all reasonable attorney's
fees.

This Note shall be governed by, and construed in accordance with, the laws of
the State of Alabama.

The Company and all endorsers and guarantors of this Note hereby waive
presentment, demand, notice of nonpayment, protest and all other demands and
notices in connection with the delivery, acceptance, performance or enforcement
of this Note.

                                  EMAGEON UV, INC.

                                  By:
                                     ------------------------------------------
                                       Its:
                                           ------------------------------------

                                       21

<PAGE>

                                   SCHEDULE A

                                       22
<PAGE>

                                    EXHIBIT B

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY
STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS
IT HAS BEEN REGISTERED UNDER SUCH ACT AND ALL SUCH APPLICABLE LAWS OR THE
TRANSFEROR THEREOF HAS PROVIDED TO THE ISSUER AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO THE COMPANY, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO
THE COMPANY, TO THE EFFECT THAT AN EXEMPTION FROM REGISTRATION IS AVAILABLE.

No. W-_____                                 Right to Purchase Shares of Common
                                            Stock of Emageon UV, Inc.

                                EMAGEON UV, INC.

                             STOCK PURCHASE WARRANT

         1. ISSUANCE. This Warrant is issued to _______________________________
(the "Holder") by EMAGEON UV, INC., a Delaware corporation (hereinafter with its
successors called the "Company"). This Warrant is one of a series of warrants
(collectively, the "Warrants") that were originally issued by the Company on
June 25, 2004 (the "Original Issue Date") pursuant to a certain Note and Warrant
Purchase Agreement, dated June 25, 2004, among the Company and the other parties
thereto (the "Purchase Agreement").

         2. NUMBER OF SHARES. Subject to the terms and conditions hereinafter
set forth, the registered Holder of this Warrant, is entitled upon surrender of
this Warrant with the subscription form annexed hereto duly executed, at the
office of the Company, at _________________________________________ or such
other office as the Company shall notify the Holder of in writing, to purchase
from the Company _____________ shares of Common Stock of the Company at a price
equal to fifty-seven cents ($0.57) per share (the "Purchase Price"); provided,
however, that (i) if the entire principal amount of the Notes issued to the
Holder pursuant to the Purchase Agreement (the "Notes") and all accrued interest
has not been repaid on or before December 25, 2005, the Holder shall thereafter
be entitled to receive, upon payment of the Purchase Price therefor, and
additional number of fully paid and non-assessable shares of Common Stock which
is equal to the number of shares that is determined when ten percent (10%) of
the then-remaining outstanding principal amount of the Notes issued to the
Holder pursuant to the Purchase Agreement is divided by 0.57; and (ii) if the
remaining principal amount of the Notes and all accrued interest has not been
repaid on or before June 25, 2007, the Company will be in default under the
Purchase Agreement and the Holder shall thereafter be entitled to receive, upon
payment of the Purchase Price therefor, and additional number of fully paid and
non-assessable shares of Common Stock which is equal to the number of shares
that is determined when twenty percent (20%) of the then-remaining outstanding
principal amount of the Notes issued to the Holder pursuant to the Purchase
Agreement is divided by 0.57.

                                       23
<PAGE>

         3. PAYMENT OF PURCHASE PRICE. The Purchase Price may be paid (i) in
cash or by cashier's check, (ii) by the surrender by the Holder to the Company
of any promissory notes or other debt obligations issued by the Company, with
all such notes and obligations so surrendered being credited against the
aggregate Purchase Price in an amount equal to the principal amount thereof plus
accrued interest to the date of surrender, or (iii) by any combination of the
foregoing. The Board shall promptly respond in writing to an inquiry by the
Holder as to the fair market value of any securities the Holder may wish to
deliver to the Company pursuant to clause (ii) above.

         4. NET ISSUE ELECTION.

               (a) In lieu of exercise pursuant to Section 3, the Holder may
elect to receive, without the payment by the Holder of any additional
consideration, shares equal to the value of this Warrant or any portion hereof
by the surrender of this Warrant or such portion to the Company, with the net
issue election notice annexed hereto duly executed, at the office of the
Company; provided, however, that the Holder may use the net issue election
provided for in this Section 4 only after the shares issuable upon exercise of
this Warrant have a readily ascertainable fair market value. For purposes of
this Section 4, the term "readily ascertainable fair market value" means a value
which can be determined by referencing trades of such shares on a securities
exchange. Thereupon, the Company shall issue to the Holder such number of fully
paid and nonassessable shares of Common Stock, if any, as is computed using the
following formula:

                                   X = Y (A-B)
                                       -------
                                          A
where

                  X =  the number of shares to be issued to the Holder
                  pursuant to this Section 4.

                  Y = the number of shares covered by this Warrant in respect of
                  which the net issue election is made pursuant to this Section
                  4.

                  A = the fair market value of one share of Common Stock, as
                  determined in accordance with (b) below, as at the time the
                  net issue election is made pursuant to this Section 4.

                  B = the Purchase Price in effect under this Warrant at the
                  time the net issue election is made pursuant to this Section
                  4.

                  (b) For purposes of this Section 4, fair market value (the
"Market Price") of a share of Common Stock as of a particular date (the
"Determination Date") shall mean the average of the closing prices of such
security's sales on the principal securities exchanges on which such security
may at the time be listed, or, if there have been no sales on any such exchange
on any day, the average of the highest bid and lowest asked prices on all such
exchanges at the end of such day, or, if on any day such security is not so
listed, the average of the last sale prices quoted by Nasdaq, or if on any day
such security is not quoted by Nasdaq, the average of the highest bid and lowest
asked prices on such day in the domestic over-the-counter

                                       24
<PAGE>

market as reported by the National Quotation Bureau, Incorporated, or any
similar successor organization, in each such case averaged over a period of five
(5) trading days consisting of the day prior to the day as of which "Market
Price" is being determined and the four (4) consecutive business days prior to
such day.

         5. PARTIAL EXERCISE. This Warrant may be exercised in part, and the
Holder shall be entitled to receive a new warrant, which shall be dated as of
the date of this Warrant, covering the number of shares in respect of which this
Warrant shall not have been exercised.

         6. ISSUANCE DATE. The person or persons in whose name or names any
certificate representing shares of Common Stock is issued hereunder shall be
deemed to have become the holder of record of the shares represented thereby as
at the close of business on the date this Warrant is exercised with respect to
such shares, whether or not the transfer books of the Company shall be closed.

         7. EXPIRATION DATE; AUTOMATIC EXERCISE. This Warrant shall expire at
the sooner of (i) the close of business on June 25, 2012, (ii) the effective
date of any merger of the Company in which the Company does not survive,
provided that the holder of this Warrant has been given prior written notice of
such event at least ten (10) business days prior thereto (which notice need not
specify the precise date of such event as long as it is given at least ten (10)
business days prior to the date on which such event actually begins), or (iii)
the effective date of the initial public offering of the Company's Common Stock,
provided that the holder of this Warrant has been given written notice of such
event at least ten (10) business days prior thereto (which notice need not
specify the precise date of such event as long as it is given at least ten (10)
business days prior to the date on which such event actually begins), and, in
each case, this warrant shall be void thereafter. Notwithstanding the foregoing,
this Warrant shall automatically be deemed to be exercised in full pursuant to
the provisions of Section 4 hereof (provided that such shares have a readily
ascertainable market value at such time), without any further action on behalf
of the Holder, immediately prior to the time this Warrant would otherwise expire
pursuant to the preceding sentence.

         8. RESERVED SHARES; VALID ISSUANCE. The Company covenants that it will
at all times from and after the date hereof reserve and keep available such
number of its authorized shares of its Common Stock free from all preemptive or
similar rights therein, as will be sufficient to permit, respectively, the
exercise of this Warrant in full of all shares of Common Stock of the Company
receivable upon such exercise. The Company further covenants that such shares as
may be issued pursuant to such exercise and conversion will, upon issuance, be
duly and validly issued, fully paid and nonassessable and free from all taxes,
liens and charges with respect to the issuance thereof.

         9. STOCK DIVIDENDS. If after the date hereof the Company shall
subdivide its Common Stock (or any other shares of stock or other securities at
the time receivable upon the exercise of this Warrant), by split-up or
otherwise, or combine the Common Stock (or any other shares of stock or other
securities at the time receivable upon the exercise of this Warrant), or issue
additional shares of Common Stock (or any other shares of stock or other
securities at the time receivable upon the exercise of this Warrant) in payment
of a stock dividend on the Common Stock (or any other shares of stock or other
securities at the time receivable upon the exercise of

                                       25
<PAGE>

this Warrant), the number of shares issuable on the exercise of this Warrant
shall forthwith be proportionately increased in the case of a subdivision or
stock dividend, or proportionately decreased in the case of a combination, and
the Purchase Price shall forthwith be proportionately decreased in the case of a
subdivision or stock dividend, or proportionately increased in the case of a
combination.

         10. MERGERS AND RECLASSIFICATIONS. Subject to Section 7 hereof, if
after the date hereof there shall be any reclassification, capital
reorganization or change of the Common Stock (other than as a result of a stock
dividend provided for in Section 9 hereof), or any consolidation of the Company
with, or merger of the Company into, another corporation or other business
organization (other than a consolidation or merger in which the Company is the
continuing corporation and which does not result in any reclassification or
change of the outstanding Common Stock), or any sale or conveyance to another
corporation or other business organization of all or substantially all of the
assets of the Company, then, as a condition of such reclassification,
reorganization, change, consolidation, merger, sale or conveyance, lawful
provisions shall be made, and duly executed documents evidencing the same from
the Company or its successor shall be delivered to the Holder, so that the
Holder shall thereafter have the right to receive the kind and amount of shares
of stock and other securities and property receivable upon such
reclassification, reorganization, change, consolidation, merger, sale or
conveyance by a holder of the number of shares of Common Stock which might have
been received by or acquired by the Holder immediately prior to such
reclassification, reorganization, change, consolidation, merger, sale or
conveyance, and in any such case appropriate provisions shall be made with
respect to the rights and interest of the Holder to the end that the provisions
hereof (including without limitation, provisions for the adjustment of the
number of shares issuable hereunder) shall thereafter be applicable in relation
to any shares of stock or other securities and property thereafter deliverable
upon exercise hereof.

         11. FRACTIONAL SHARES. In no event shall any fractional shares of
Common Stock of the Company be issued upon any exercise of this Warrant. If,
upon exercise of this Warrant as an entirety, the Holder would, except as
provided in this Section 11, be entitled to receive a fractional share of Common
Stock of the Company, then the Company shall issue the next higher number of
full shares of Common Stock, issuing a full share with respect to such
fractional share.

         12. CERTIFICATE OF ADJUSTMENT. Whenever the number of shares issuable
hereunder is adjusted, as herein provided, the Company shall promptly deliver to
the Holder a certificate setting forth the number of shares issuable hereunder
after such adjustment and setting forth a brief statement of the facts requiring
such adjustment.

         13.  NOTICES OF RECORD DATE, ETC.  In the event of:

         (i)      any taking by the Company of a record of the holders of any
                  class of securities for the purpose of determining the holders
                  thereof who are entitled to receive any dividend or other
                  distribution, or any right to subscribe for, purchase or
                  otherwise acquire any shares of stock of any class or any
                  other securities or property, or to receive any other right,

                                       26

<PAGE>

         (j)      any reclassification of the capital stock of the Company,
                  capital reorganization of the Company, consolidation or merger
                  involving the Company, or sale or conveyance of all or
                  substantially all of its assets, or

         (k)      any voluntary or involuntary dissolution, liquidation or
                  winding-up of the Company,

then and in each such event the Company will mail or cause to be mailed to the
Holder a notice specifying (i) the date on which any such record is to be taken
for the purpose of such dividend, distribution or right, and stating the amount
and character of such dividend, distribution or right, or (ii) the date on which
any such reclassification, reorganization, consolidation, merger, sale or
conveyance, dissolution, liquidation or winding-up is to take place, and the
time, if any is to be fixed, as of which the holders of record in respect of
such event are to be determined. Such notice shall be mailed at least twenty
(20) days prior to the date specified in such notice on which any such action is
to be taken.

         14. AMENDMENT. The terms of this Warrant may be amended, modified or
waived only with the written consent of the Company and the holders of at least
66-2/3% of the outstanding principal amount of the Notes issued pursuant to the
Purchase Agreement. No such amendment, modification or waiver shall be effective
as to this Warrant unless the terms of such amendment, modification or waiver
shall apply with the same force and effect to all of the other Warrants then
outstanding.

         15. WARRANT REGISTER; TRANSFERS, ETC. (a) The Company will maintain a
                  register containing the names and addresses of the registered
                  holders of the Warrants. The Holder may change its address as
                  shown on the warrant register by written notice to the Company
                  requesting such change. Any notice or written communication
                  required or permitted to be given to the Holder may be given
                  by certified mail or delivered to the Holder at its address as
                  shown on the warrant register.

         (b)      This Warrant and the shares exercisable or exercised pursuant
                  to this Warrant ("Warrant Shares") may be transferred by the
                  Holder only if (i) such transfer is made in accordance with
                  applicable federal and state securities laws, (ii) Holder
                  transfers this Warrant and such Warrant Shares in their
                  entirety, (iii) such transfer is made to a third party who or
                  that acquires the Note or Notes held by the Holder in their
                  entirety and who or that is not reasonably considered to be a
                  competitor of the Company by the Company and the Holder, and
                  (iv) such transfer is made in accordance with this subsection
                  (b). Upon surrender of this Warrant to the Company, together
                  with the assignment hereof properly endorsed, for transfer of
                  this Warrant as an entirety by the Holder, the Company shall
                  issue a new warrant of the same denomination to the assignee.
                  Holder agrees that, absent an effective registration statement
                  filed with the Securities & Exchange Commission under the
                  Securities Act of 1933, as amended, covering the disposition
                  or sale of this Warrant or the Warrant Shares issued or
                  issuable upon exercise hereof, as the case may be, and
                  registration or qualification applicable state securities
                  laws, Holder will not sell, transfer, pledge, hypothecate or
                  otherwise dispose any or all such Warrants or Warrant Shares,
                  as the case may be, unless either (A) the Company

                                       27

<PAGE>

                  has received an opinion of counsel, in form and substance
                  reasonably satisfactory to the Company, to the effect that
                  such registration is not required in connection with such
                  disposition or (B) the sale of such securities is made
                  pursuant to Securities & Exchange Commission Rule 144.

         (c)      In case this Warrant shall be mutilated, lost, stolen or
                  destroyed, the Company shall issue a new warrant of like tenor
                  and denomination and deliver the same (i) in exchange and
                  substitution for and upon surrender and cancellation of any
                  mutilated Warrant, or (ii) in lieu of any Warrant lost, stolen
                  or destroyed, upon receipt of evidence reasonably satisfactory
                  to the Company of the loss, theft or destruction of such
                  Warrant (including a reasonably detailed affidavit with
                  respect to the circumstances of any loss, theft or
                  destruction) and of indemnity reasonably satisfactory to the
                  Company, provided, however, that so long as any purchaser
                  named in Schedule I to the Purchase Agreement is the
                  registered holder of this Warrant, no indemnity shall be
                  required other than its written agreement to indemnify the
                  Company against any loss arising from the issuance of such new
                  warrant.

         16. NO IMPAIRMENT. The Company will not, by amendment of its Articles
of Incorporation or through any reclassification, capital reorganization,
consolidation, merger, sale or conveyance of assets, dissolution, liquidation,
issue or sale of securities or any other voluntary action, avoid or seek to
avoid the observance or performance of any of the terms of this Warrant, but
will at all times in good faith assist in the carrying out of all such terms and
in the taking of all such action as may be necessary or appropriate in order to
protect the rights of the Holder.

         17. INVESTMENT INTENT. By accepting this Warrant, the Holder hereof
shall be deemed to have made all of those representations and warranties
contained in Article III of the Purchase Agreement as they relate to this
Warrant and the securities issuable upon exercise hereof.

         18. NO RIGHTS OR LIABILITY AS A STOCKHOLDER. This Warrant does not
entitle the Holder hereof to any voting rights or other rights as a stockholder
of the Company. No provisions hereof, in the absence of affirmative action by
the Holder hereof to exercise this Warrant hereunder, and no enumeration herein
of the rights or privileges of the Holder hereof shall give rise to any
liability of such Holder as a stockholder of the Company.

         19. GOVERNING LAW. The provisions and terms of this Warrant shall be
governed by and construed in accordance with the internal laws of the State of
Delaware.

         20. SUCCESSORS AND ASSIGNS. This Warrant shall be binding upon the
Company's successors and assigns and shall inure to the benefit of the Holder's
successors, legal representatives and permitted assigns.

         21. BUSINESS DAYS. If the last or appointed day for the taking of any
action required or the expiration of any right granted herein shall be a
Saturday or Sunday or a legal holiday in Alabama, then such action may be taken
or right may be exercised on the next succeeding day which is not a Saturday or
Sunday or such a legal holiday.

                                       28

<PAGE>

         22. MARKET STAND-OFF AGREEMENT. The Holder hereby agrees that, during
the period specified by the managing underwriter of an underwritten public
offering of equity securities of the Company for the account of the Company or
any Holder hereunder (but in any event not to exceed ninety (90) days following
the effective date of the registration statement relating to such underwritten
public offering or one hundred and eighty (180) days following the effective
date of a registration statement relating to an initial public offering of the
Company's securities), the Holder shall not, to the extent requested by such
managing underwriter, directly or indirectly, effect any sale of any equity
securities of the Company except pursuant to such registration.

Dated:  June 25, 2004                  EMAGEON UV, INC.

                                       By:
                                          -------------------------------------
                                          Its:
                                              ---------------------------------

                                       29

<PAGE>

                                  Subscription

To:____________________                          Date:_________________________

         The undersigned hereby subscribes for __________ shares of Common Stock
covered by this Warrant. The certificate(s) for such shares shall be issued in
the name of the undersigned or as otherwise indicated below:

                                        ----------------------------------------
                                        Signature

                                        ----------------------------------------
                                        Name for Registration

                                        ----------------------------------------
                                        Mailing Address

                            Net Issue Election Notice

To:____________________                           Date:_________________________

         The undersigned hereby elects under Section 4 to surrender the right to
purchase _______ shares of Common Stock pursuant to this Warrant. The
certificate(s) for the shares issuable upon such net issue election shall be
issued in the name of the undersigned or as otherwise indicated below.

                                       -----------------------------------------
                                       Signature

                                       -----------------------------------------
                                       Name for Registration

                                       -----------------------------------------
                                       Mailing Address

                                       30

<PAGE>

                                   Assignment

         For value received                              hereby sells,
                            ----------------------------
assigns and transfers unto
                           -----------------------------------------------------

--------------------------------------------------------------------------------

    Please print or typewrite name and address of Assignee

--------------------------------------------------------------------------------

the within Warrant, and does hereby irrevocably constitute and appoint
                        its attorney to transfer the within Warrant on the books
-----------------------
of the within named Company with full power of substitution on the premises.

Dated:
      -----------------------

                                                       -------------------------
In the Presence of:

-----------------------------

                                       31
<PAGE>

                                    EXHIBIT C

                       CHARTER AND ALL AMENDMENTS THERETO

                                       32<PAGE>

                                                                   EXHIBIT 10.15

                                  EMAGEON, INC.
                   AMENDED AND RESTATED STOCKHOLDERS AGREEMENT

         THIS AMENDED AND RESTATED STOCKHOLDERS AGREEMENT ("Agreement"), made
this 2nd day of October, 2001, by and among EMAGEON, INC., a Delaware
corporation (the "Company"); those holders of the Company's Common Stock listed
on Schedule 1 attached hereto (the "Common Stockholders"); those holders of the
Company's Series A Preferred Stock listed on Schedule 2 attached hereto (the
"Series A Investors"); those holders of the Company's Series B Preferred Stock
listed on Schedule 3 attached hereto (the "Series B Investors"); those holders
of the Company's Series B-1 Preferred Stock listed on Schedule 4 attached hereto
(the "Series B-1 Investors"); and those holders of the Company's Series C
Preferred Stock listed on Schedule 5 attached hereto (the "Series C Investors"
and together with the Series A Investors, the Series B Investors and the Series
B-1 Investors collectively, the "Investors");

                                   WITNESSETH:

         WHEREAS, the Common Stockholders are holders of substantially all of
the issued and outstanding shares of the Company's Common Stock, $0.001 par
value ("Common Stock");

         WHEREAS, Charles A. Jett, Jr. ("Jett") is a Common Stockholder and is
the Chief Executive Officer of the Company;

         WHEREAS, the Series A Investors are the holders of all of the issued
and outstanding shares of the Company's Series A Preferred Stock, $0.001 par
value (the "Series A Preferred"), the Series B Investors are the holders of all
of the issued and outstanding shares of the Company's Series B Preferred Stock,
$0.001 par value (the "Series B Preferred"), the Series B-1 Investors are the
holders of all of the issued and outstanding shares of the Company's Series B-1
Preferred Stock, $0.001 par value (the "Series B-1 Preferred"), and the Series C
Investors are the holders of all of the issued and outstanding shares of the
Company's Series C Preferred Stock, $0.001 par value, (the "Series C Preferred"
and together with the Series A Preferred, Series B Preferred and Series B-1
Preferred, collectively, the "Preferred Stock");

         WHEREAS, the Common Stockholders have entered into a Common
Stockholders Agreement, dated January 10, 2000, by and among the Company and the
holders of all of the outstanding shares of Common Stock, as amended as of June
26, 2000 (the "Common Agreement");

         WHEREAS, the Series A Investors have entered into a Series A Preferred
Stockholders Agreement, dated January 10, 2000, by and among the Company and the
holders of all of the outstanding shares of Series A Preferred, as amended as of
June 26, 2000 (the "Series A Agreement");

<PAGE>

         WHEREAS, the Series B Investors have entered into a Stockholders
Agreement, dated June 26, 2000, by and among the Company, the holders of all of
the outstanding shares of Series B Preferred and certain Common Stockholders
(the "Series B Agreement");

         WHEREAS, the Series A Investors, the Series B Investors and the Common
Stockholders have entered into an Investor Rights Agreement, dated as of June
26, 2000 (the "Investor Rights Agreement"); and

         WHEREAS, in connection with the purchase of the Series C Preferred by
the Series C Investors pursuant to a Series C Preferred Stock Purchase Agreement
of even date herewith, the Company, the Investors and the Common Stockholders
desire to terminate (and waive their rights thereunder) the existing Series A
Agreement, Series B Agreement, Common Agreement and the Investor Rights
Agreement, and replace such agreements with this Agreement, which shall set
forth certain of the rights and obligations of the Investors and Common
Stockholders with respect to the Shares (as hereinafter defined) held by them.

         NOW, THEREFORE, in consideration of the premises, and the mutual terms
and conditions set forth herein, it is hereby agreed by and among the Company,
the Common Stockholders and the Investors that all the shares of capital stock
of Company (which for purposes of this Agreement include options, warrants and
other rights to acquire capital stock) owned or held at any time by any Investor
or Common Stockholder or by any transferee thereof (the "Shares") shall be
subject to the following agreements:

         1. TRANSFER OF SHARES. No transfer or sale by any Common Stockholder or
Investor of the Shares shall be permitted, including without limitation, a sale
or transfer of Shares to any entity not a party to this Agreement, except
pursuant to the provisions of this Agreement; provided, however, that all or any
portion of the Shares may be transferred by a Common Stockholder or Investor in
a Permitted Transfer. For purposes of this Agreement, "Permitted Transfers"
shall mean: (a) transactions not involving a change in beneficial ownership; (b)
transactions involving distribution without consideration by a partnership to
any of its partners, retired partners or to the estate of any of its partners,
or by a limited liability company to any of its members, retired members or to
the estate of any of its members; (c) transfers by an individual to a trust for
the benefit of such individual or his family; (d) transfers by gift, will or
intestate succession to the spouse, lineal descendants or ancestors of any
Common Stockholder or Investor; or (e) transfers to any person or entity that
directly or indirectly, through one or more intermediaries, has control of or is
controlled by, or is under common control with the Common Stockholder or
Investor. Each transferee in a Permitted Transfer after the date of this
Agreement shall execute and deliver to Company a counterpart of this Agreement
as a condition to the effectiveness of such Permitted Transfer. Upon such
execution and delivery, copies of such counterparts shall be delivered by
Company to Common Stockholders and Investors.

                                       2
<PAGE>

         2.       PROCEDURE FOR DISPOSITION OF SHARES.

                  (a) RESTRICTION ON TRANSFER. Any Common Stockholder or
Investor who desires to sell all or any portion of the Shares held by such
person or entity (as used in this Section 2, the "Selling Stockholder") and who
has received a bona fide offer to purchase the Shares, shall only transfer the
Shares in accordance with the following provisions of this Section 2.
Notwithstanding the provisions set forth herein, until the second anniversary
date of this Agreement, Jett shall not sell his Shares unless (i) he first
obtains the written consent of the Board of Directors, or (ii) such transfer of
Shares is in connection with a Board-approved Sale of the Company (as defined in
Section 3(a) hereof).

                  (b) OFFER TO COMPANY. The Selling Stockholder shall give to
Company and all Investors written notice (the "Notice") of his or her intention
to sell the Shares (the "Offered Shares"), which Notice shall specify the
following:

                  i.       Name, address and telephone number of the proposed
                           purchaser;

                  ii.      Price and proposed terms of payment;

                  iii.     Number of Shares to be purchased;

                  iv.      Date of proposed sale; and

                  v.       All other material terms of the sale.

                  (c) RIGHT TO PURCHASE. The Company shall then have the right
to purchase all (or any portion) of the Offered Shares in accordance with the
terms set forth in the Notice; provided, however, that Company must notify the
Selling Stockholder within thirty (30) days of receipt of such Notice of its
intention to purchase all or a portion of the Offered Shares.

                  (d) OFFER TO SERIES B INVESTORS, SERIES B-1 INVESTORS AND
SERIES C INVESTORS. In the event the Company shall decide not to purchase all
the Offered Shares, Company shall notify each of the Series B Investors, Series
B-1 Investors and Series C Investors of such decision within thirty (30) days
after receipt of the Notice. The Series B Investors, Series B-1 Investors and
Series C Investors shall have the right to purchase all (or any portion) of the
Offered Shares in accordance with the terms set forth in the Notice on a pro
rata basis determined by each such party's proportionate ownership interest of
all outstanding Shares held by the Series B Investors, Series B-1 Investors and
Series C Investors. In the event a Series B Investor, Series B-1 Investor or
Series C Investor elects not to acquire its (or their) entire proportionate
interest, the remaining Series B Investors, Series B-1 Investors and Series C
Investors shall be entitled to acquire the remainder of such interest on a pro
rata basis as described above; provided, however, that the Investors must notify
the Selling Stockholder (and the Company) of their intention to purchase such
shares within thirty (30) days from the date the Notice was

                                       3
<PAGE>

delivered to the Company and the Series B Investors, Series B-1 Investors and
Series C Investors. Investors holding a majority of the issued and outstanding
Series B Preferred, Series B-1 Preferred and Series C Preferred (voting together
as a single class) may waive for such Investors the rights of first refusal
contained herein if such Investors deem the transfer of the Shares of the
Selling Stockholder to the person named in the Notice to be in the best interest
of the Investors and/or Company.

                  (e) OFFER TO SERIES A INVESTORS AND COMMON STOCKHOLDERS. In
the event the Company, the Series B Investors, Series B-1 Investors and Series C
Investors shall decide not to purchase all the Offered Shares, Company shall
notify each of the Series A Investors and Common Stockholders of such decision
within thirty (30) days after receipt of the Notice. The Series A Investors and
Common Stockholders shall have the right to purchase all (or any portion) of the
remaining Offered Shares in accordance with the terms set forth in the Notice on
a pro rata basis determined by each such party's proportionate ownership
interest of all outstanding Shares held by the Series A Investors and Common
Stockholders. In the event a Series A Investor or Common Stockholder elects not
to acquire its (or their) entire proportionate interest, the remaining Series A
Investors and Common Stockholders shall be entitled to acquire the remainder of
such interest on a pro rata basis as described above; provided, however, that
the Series A Investors and Common Stockholders must notify the Selling
Stockholder (and the Company) of their intention to purchase such shares within
thirty (30) days from the date the Notice was delivered to the Series A
Investors and Common Stockholders. Series A Investors and Common Stockholders
holding a majority of the issued and outstanding Series A Preferred and Common
Stock (voting together as a single class) may waive for such Series A Investors
and Common Stockholders the rights of first refusal contained herein if such
Series A Investors and Common Stockholders deem the transfer of the Shares of
the Selling Stockholder to the person named in the Notice to be in the best
interest of the Investors and/or Company.

                  (f) SALE TO THIRD PARTY. In the event the Common Stockholders,
Investors or Company do not notify the Selling Stockholder of their or its
intention to exercise the rights set forth in Sections 2(c), 2(d) and 2(e)
hereof within the time period specified therein to purchase all of the Offered
Shares, the Selling Stockholder shall have the right for one hundred and twenty
(120) days after the date of the Notice to consummate the transaction (with
respect to any remaining Shares) outlined in the Notice subject to the
provisions of Section 2(f) hereof and the other provisions of this Agreement;
provided, however, that no sale shall be made hereunder unless the purchaser
agrees to be bound by the terms of this Agreement and has executed an agreement
to that effect. Upon the expiration of the one hundred and twenty (120) day
period set forth above, the Selling Stockholder must comply with all the
provisions of this Section 2 prior to making any further sale of such Shares.

                  (g) RIGHT OF CO-SALE. In the event a Selling Stockholder
disposes of Shares pursuant to Section 2(f) hereof, each Investor shall have the
right to sell a proportionate number of shares of capital stock (determined by
the number of Shares (on an as-converted basis) held by such Investor divided by
the number of Shares (on as as-

                                       4
<PAGE>

converted basis) held by the Selling Stockholder and the Investors that exercise
this co-sale right) to the third party acquiring the Selling Stockholder's
Shares, on the same terms as outlined in the Notice, in accordance with the
following procedure:

                           i. The Selling Stockholder shall, prior to sale, give
written notice to each Investor of its right of co-sale.

                           ii. Each Investor shall have ten (10) days to
determine if it desires to sell Shares to the third party acquiring the Selling
Stockholder's Shares.

                  (h) FAILURE TO DELIVER SHARES. If a Selling Stockholder
becomes obligated to sell to an Investor or Common Stockholder under this
Agreement any Shares, and the Selling Stockholder fails to comply with its
obligations hereunder relating to the delivery of certificates for the Shares,
such Investor may, at its option, in addition to all other remedies it may have,
send to Company for the benefit of such Selling Stockholder the purchase price
for such Shares as is herein specified. Thereupon, Company, upon written notice
to such Selling Stockholder, (i) shall cancel on its books the certificate(s)
representing the Shares to be sold, and (ii) shall issue, in lieu thereof, in
the name of such Investor a new certificate(s) representing such Shares, and
thereupon all of such Selling Stockholder's rights in and to such Shares shall
terminate. Company may exercise a similar remedy in enforcing its rights
hereunder.

         3.       DRAG-ALONG RIGHTS.

                  (a) In the event of a Sale of the Company, as hereinafter
defined, which is approved by the holders of at least 60% of the
then-outstanding Series B Preferred, Series B-1 Preferred and Series C Preferred
(voting together as a single class on an as-converted basis), each Investor and
each Common Stockholder shall vote all shares of Preferred Stock and/or Common
Stock (including Shares of Common Stock issued upon conversion of Preferred
Stock) held by him or it in favor of the Sale of the Company. For purposes of
the foregoing, "Sale of the Company" shall mean (i) the purchase of
substantially all of the assets of the Company, or (ii) the sale, transfer or
exchange of all or substantially all of the Company's issued and outstanding
capital stock, whether by merger, share exchange, consolidation, sale of all of
the outstanding capital stock or otherwise.

                  (b) By execution of this Agreement, each Common Stockholder
and each Investor hereby agrees to vote all shares of Preferred Stock and/or
Common Stock held by him or it (including all Shares acquired after the date
hereof by purchase, conversion or otherwise) in accordance with Section 3(a)
hereof and to take such further actions as may be reasonably necessary to effect
the provisions of Section 3(a).

         4. PROHIBITION AGAINST TRANSFER TO COMPETITORS. For purposes of this
Section 4, "competitor of the Company" shall mean any company that is engaged in
the digital storage or viewing of diagnostic medical images. Notwithstanding any
provision of this Agreement to the contrary, except in connection with a Sale of
the Company, no

                                       5
<PAGE>

Common Stockholder or Investor shall sell or otherwise transfer any Shares to
any person or entity that is a competitor of the Company or is affiliated with a
competitor of the Company.

         5. PROHIBITION AGAINST PLEDGE OF STOCK. No Common Stockholder or
Investor shall pledge, hypothecate or grant a security interest in all or any
part of the Shares (other than pledges, hypothecations or security interests
granted to lenders in connection with loans to purchase Shares) without the
consent of the holders of at least 60% of the Series B Preferred, Series B-1
Preferred and Series C Preferred (voting together as a single class).

         6. LEGEND. Each certificate for capital stock in Company held by any
Common Stockholder and any Investor shall be presented to Company and the
following legend shall be placed on it:

         "THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR
         TRANSFERRED WITHOUT COMPLIANCE WITH THE TERMS OF AN AMENDED AND
         RESTATED STOCKHOLDERS AGREEMENT DATED AS OF OCTOBER 2, 2001 AMONG
         COMPANY AND CERTAIN STOCKHOLDERS OF COMPANY, A COPY OF WHICH AGREEMENT
         IS ON FILE IN THE OFFICE OF THE SECRETARY OF COMPANY. THE AGREEMENT
         PROVIDES FOR CERTAIN RESTRICTIONS ON TRANSFER AND RIGHTS TO PURCHASE."

         7. BOARD OF DIRECTORS. From and after the date hereof, and until the
provisions of this Section 7 cease to be effective as provided below, each
Common Stockholder and Investor shall vote any voting security of Company over
which such Common Stockholder or Investor has voting control, and shall take all
other necessary or desirable actions (including, without limitation, attendance
at meetings in person or by proxy for purposes of obtaining a quorum and
execution of written consents in lieu of meetings), and Company shall take all
necessary and desirable actions (including, without limitation, calling special
Board of Directors and Stockholder meetings), in accordance with the following
provisions:

                  (a) CONSTITUENCY OF BOARD OF DIRECTORS; QUORUM. Pursuant to
the Amended and Restated Certificate of Incorporation of the Company (the
"Certificate"), the Common Stockholders and Investors shall vote their shares of
capital stock of Company for a Board of Directors consisting of seven (7)
directors. For so long as the outstanding Shares of Series A Preferred
constitute five percent (5%) or more of the Company's outstanding capital stock
(on a fully diluted basis), the Series A Investors, voting separately as a
class, shall have the right to elect one (1) director (the "Series A Director")
(and to fill any vacancies with respect thereto) by a vote of a majority of the
then outstanding shares of Series A Preferred. In connection therewith, the
Series A Investors shall designate one person as nominee for director and such
Series A Investors agree to designate and vote their Shares in favor of such
nominee. For so long as the

                                       6
<PAGE>

outstanding Shares of Series B Preferred and Series B-1 Preferred, collectively,
constitute five percent (5%) or more of the Company's outstanding capital stock
(on a fully diluted basis), the Series B Investors and the Series B-1 Investors,
voting together and separately as a class, shall have the right to elect one (1)
director (the "Series B Director"). In connection therewith, the Series B
Investors and Series B-1 Investors shall designate one person as nominee for
director and such Series B Investors and Series B-1 Investors agree to designate
and vote their Shares in favor of such nominee. The initial Series B Director
shall be designated by STF Institutional Partners II, L.P. For so long as the
outstanding Shares of Series C Preferred constitute five percent (5%) or more of
the Company's outstanding capital stock (on a fully diluted basis), the Series C
Investors, voting separately as a class, shall have the right to elect two (2)
directors (the "Series C Directors") (and to fill any vacancies with respect
thereto) by a vote of a majority of the then outstanding shares of Series C
Preferred. One (1) Series C Director initially shall be designated by Investors
holding a majority of the Shares of Series C Preferred and the other Series C
Director shall be Paul Reaves. Each of the Series C Investors shall vote their
Series C Shares in favor of such designee and such nominee. Each of the parties
shall vote their shares of capital stock of Company to elect Jett as a director
while Jett remains an employee of Company. Any other members of the Board of
Directors authorized by the Corporation's Bylaws shall be elected by the Common
Stockholders and Investors voting together as a single class. A majority of the
number of directors then constituting the Board of Directors shall constitute a
quorum for the transaction of business of the Board of Directors.

                  (b) EXECUTIVE COMMITTEE. The Board of Directors shall
establish an Executive Committee consisting of three (3) members, which shall be
comprised of the Series B Director, one (1) Series C Director and Jett.

                  (c) AUDIT COMMITTEE. The Board of Directors shall establish an
Audit Committee following the date hereof comprised of at least the Series B
Director, one (1) director designated by Jett and at least one (1) Series C
Director.

                  (d) COMPENSATION COMMITTEE. The Board of Directors shall
establish a Compensation Committee consisting of three (3) directors, which
shall be comprised of at least one Series C Director, the Series B Director and
Jett.

                  (e) OTHER COMMITTEES. Any other committee of the Board of
Directors shall be created only upon the approval of a majority of the members
of the Board of Directors and each such committee (if any) shall include the
Series B Director and at least one Series C Director.

                  (f) VACANCIES; REMOVAL. In the event that any person for any
reason ceases to serve as a member of the Board of Directors or any committee
thereof during such person's term of office, the resulting vacancy on the Board
of Directors or committee shall be filled by a representative designated by the
persons referred to in subsections (a) through (e) of this Section 7.

                                       7
<PAGE>

                  (g) MEETINGS. Any holder (including any other holder that
controls, is controlled by or is under common control with such holder) of at
least twenty percent (20%) of the Preferred Stock (as adjusted for any
combination, consolidation, stock distribution or stock dividend with respect to
such shares) shall (i) be entitled to notice of, (ii) have the right to attend,
(iii) receive copies of all materials distributed to Directors in connection
with, and (iv) comment for the record at, any and all Board of Directors
meetings.

                  (h) BOARD EXPENSES. Company shall pay all direct out-of-pocket
expenses reasonably incurred by directors in attending each meeting of the Board
of Directors or any committee thereof.

                  (i) NO CONFLICTING AGREEMENTS. Each Investor and Common
Stockholder represents that it has not granted and is not a party to any proxy,
voting trust or other agreement which is inconsistent with or conflicts with the
provisions of this Agreement, and no Investor or Common Stockholder shall grant
any proxy or become party to any voting trust or other agreement which is
inconsistent with or conflicts with the provisions of this Agreement.

                  (j) OBSERVER RIGHTS. STF Institutional Partners II, L.P. shall
have the non-assignable right to send one (1) representative to attend in a
nonvoting observer capacity all meetings of the Board of Directors (whether held
in person or via telephone conference). The Company may reasonably permit
representatives of other Investors to also attend, in a nonvoting observer
capacity, meetings of the Board of Directors (whether held in person or via
telephone conference). Such representatives may participate in all discussions
of matters brought to the Board of Directors, and may receive notices, minutes,
consents and other materials, financial and otherwise, which the Company
provides to the Board of Directors; provided, however, that the Company reserves
the right to exclude any such representative from access to any material or
meeting or portion thereof if the Company believes upon advice of counsel that
such exclusion is reasonably necessary. The Company may provide each such
representative with copies of any written actions by consent of the Board of
Directors at the same time they are submitted to the members of the Board of
Directors. All representatives shall execute a confidentiality agreement in form
and substance reasonably satisfactory to the Board of Directors with respect to
the information and discussions to which such representative has access pursuant
to this Section 7(j).

                  (k) NATURE AND TERM OF AGREEMENT. The provisions of this
Section 7, which require Stockholders to vote their shares in accordance with
the terms set forth herein, shall constitute a voting agreement under Section
218 of the Delaware General Corporation Law and shall terminate automatically
and be of no further force and effect upon the occurrence of a Qualifying IPO
(as such term is defined in the Certificate).

         8. COMPANY COVENANTS. Company hereby covenants and agrees as follows:

                  (a)    BASIC FINANCIAL INFORMATION AND REPORTING REQUIREMENTS.

                                       8
<PAGE>

                           (i)    Reports and Notifications to Be Delivered by
Company. Unless waived, Company shall furnish to each Investor the following
reports and notices so long as such holder continues to hold at least 50,000
Shares of Preferred Stock; provided, that, in the case of affiliated Series A
Investors, Series B Investors, Series B-1 Investors or Series C Investors,
Company shall only be obligated to furnish the following reports and notices to
one representative of such affiliated Series A Investors, Series B Investors,
Series B-1 Investors or Series C Investors.

                           (ii) Annual Financial Statements. As soon as
practicable after the end of each fiscal year, and in any event within ninety
(90) days thereafter, Company shall furnish to each Investor audited
consolidated and consolidating balance sheets of Company and its subsidiaries,
if any, as at the end of such fiscal year, and audited consolidated and
consolidating, statements of income, retained earnings and cash flows of Company
and its subsidiaries, if any, for such fiscal year, prepared in accordance with
generally accepted accounting principles ("GAAP") and setting forth in each case
in comparative form the figures for the previous fiscal year, if any, all in
reasonable detail and accompanied by: (A) a report and opinion thereon by
independent certified public accountants of national reputation; i.e., a "Big
Five" firm or equivalent, who shall be approved by the Board of Director's Audit
Committee; and (B) a copy of such accountants' management letter prepared in
connection therewith, if any (as soon as such letter is available, which may be
greater than the aforesaid ninety (90) day period).

                           (iii) Monthly Reports. As soon as practicable after
the end of each calendar month, but in any event within thirty (30) days
thereafter, "Monthly Financial Statements" consisting of:

                                    (A) the unaudited consolidated balance sheet
of Company and its subsidiaries, if any, as of the end of such month;

                                    (B) unaudited profit and loss statement,
cash flow statement and backlog statement of Company and its subsidiaries for
such month and year to date;

                                    (C) actual results versus Company's and its
subsidiaries', if any, plan for the month and year to date, and commencing in
2002, setting forth in each case in comparative form the figures for the
corresponding month and year to date period of the preceding fiscal year;

                                    (D) a 12-month cash forecast; and

                                    (E) a brief (1 page) management summary of
operations,

all in reasonable detail and prepared consistently with GAAP and certified by
the principal financial or accounting officer of Company.

                                       9
<PAGE>

                           (iv) Additional Quarterly Report. As soon as
practicable after the end of each fiscal quarter, and in any event within
forty-five (45) days thereafter, a brief (1-2 pages) quarterly report of the
President of Company describing important operational activities during the
prior quarter, and including data on new customers, customer attrition and legal
matters.

                           (v) Annual Operating Plan. At least thirty (30) days
prior to the beginning of each fiscal year, a comprehensive written operating
plan to include projections for the next twelve (12) months in the same format
as the Monthly Financial Statements. All such projections shall represent the
good faith estimate of management as to future operations, but it is
acknowledged that such projections are not intended and shall not be deemed to
guarantee the future operations of Company or its subsidiaries, if any.

                           (vi) Notification of Defaults Under Material
Agreements. Within ten (10) days after receipt thereof, copies of any
notifications received by Company or any of its subsidiaries, if any, from its
or their lenders, landlords, or other parties, alleging default under any
material loans, financing transactions, leases or similar agreements to which
Company or any of its subsidiaries, if any, is a party.

                           (vii) Notification of Litigation Proceedings. Within
ten (10) days after the Company receives notice thereof, notice of all actions,
suits and proceedings before any court or governmental department, commission,
board, bureau, agency or instrumentality, domestic or foreign, affecting Company
or any subsidiary (including, without limitation, all material actions filed by
or against Company) in such a manner as to be reasonably likely to cause a
material adverse effect on the Company and its subsidiaries, taken as a whole.

                           (viii) Other Reports. With reasonable promptness,
such other information respecting the business, properties or the condition of
operations, financial or other, of Company or any of its subsidiaries, if any,
as an Investor may from time to time reasonably request; provided, however, that
the Company shall not be obligated under this Section 8(a) to provide
information which it deems in good faith to be a trade secret or similar
confidential information.

                           (ix) Assignability of Rights to Receive Reports and
Notifications. The rights granted pursuant to this Section 8(a) may be assigned
only in connection with a transfer of an Investor's Preferred Shares and may not
be assigned or otherwise conveyed by Investors or by any subsequent transferee
of any such rights without the written consent of Company, which consent shall
not be unreasonably withheld; provided, however, that Company may refuse such
written consent if the proposed transferee is reasonably believed by Company to
be, directly or indirectly, a competitor of Company or affiliated with a
competitor of Company or if the proposed transferee has refused to sign a
reasonable, written confidentiality agreement with Company; and provided
further, that no such written consent shall be required if the

                                       10
<PAGE>

transfer is a Permitted Transfer by Investors, unless the proposed transferee in
such Permitted Transfer is reasonably believed by the Company to be a
competitor, directly or indirectly, of Company or affiliated with a competitor
of Company.

                  (b) ADDITIONAL AFFIRMATIVE COVENANTS. Company covenants and
agrees that it will perform and observe the following covenants and provisions,
and will cause each subsidiary of Company, if and when such subsidiary exists,
to perform and observe such of the following covenants and provisions as are
applicable to such subsidiary:

                           (i)  Preservation of Corporate Existence.

                                (A) Preserve and maintain and, unless Company
deems it not to be in its best interests, cause each subsidiary to preserve and
maintain, its corporate existence, rights, franchises and privileges in the
jurisdiction of its incorporation, and qualify and remain qualified, and cause
each subsidiary to qualify and remain qualified, as a foreign corporation in
each jurisdiction in which such qualification is necessary or desirable in view
of its business and operations or the ownership or lease of its properties.

                                (B) Secure, preserve and maintain, and cause
each subsidiary to secure, preserve and maintain, all licenses and other rights
to use patents, processes, licenses, permits, trademarks, trade names,
inventions, intellectual property rights or copyrights owned or possessed by it
and deemed by Company to be necessary to the conduct of its business or the
business of any subsidiary.

                           (ii) Payment of Taxes. Pay and discharge, and cause
each subsidiary to pay and discharge, all taxes, assessments and governmental
charges or levies imposed upon it or upon its income, profits or business, or
upon any properties belonging to it, prior to the date on which penalties attach
thereto, and all lawful claims which, if unpaid, might become a lien or charge
upon any properties of Company or any subsidiary, provided that neither Company
nor any subsidiary shall be required to pay any such tax, assessment, charge,
levy or claim which is being contested in good faith and by appropriate
proceedings if Company or the applicable subsidiary shall have set aside on its
books sufficient reserves, if any, with respect thereto.

                           (iii) Payment of Trade Debt. Pay, and cause each
subsidiary to pay, when due, or in conformity with customary trade terms, all
lease obligations, all trade debt, and all other indebtedness incident to the
operations of Company or its subsidiaries, except such as are being contested in
good faith and by proper proceedings if Company or the applicable subsidiary
shall have set aside on its books sufficient reserves, if any, with respect
thereto.

                           (iv)  Maintenance of Properties. Maintain and
preserve, and cause each subsidiary to maintain and preserve, all of its
properties and assets, necessary

                                       11
<PAGE>

for the proper conduct of its business, in good repair, working order and
condition, ordinary wear and tear excepted.

                           (v)  Maintenance of Insurance.

                                (A) Maintain or cause to be maintained, and
cause each subsidiary to maintain, insurance with responsible and reputable
insurance companies or associations in such amounts and covering such risks as
is customarily carried by companies engaged in similar businesses and owning
similar properties in the same general areas in which Company or such subsidiary
operates.

                                (B) Maintain or cause to be maintained a policy
or policies of directors' and officers' liability insurance with responsible and
reputable insurance companies or associations, covering the directors and
officers of Company and its subsidiaries in such amounts and against such risks
as is customarily carried by companies engaged in similar businesses to that of
Company, and on such terms and conditions as shall be reasonably acceptable to
each of the Series A Director, the Series B Director and each Series C Director.

                           (vi) Inspection. Permit any Investor and each
transferee of the foregoing in a Permitted Transfer, its attorney or its other
representative to visit and inspect Company's and, its subsidiaries' properties,
to examine Company's and its subsidiaries' books of account and other records,
to make copies or extracts therefrom and to discuss Company's and its
subsidiaries' affairs, finances and accounts with their officers, management
employees and independent accountants all at such reasonable times and as often
as such holder or such transferee may reasonably request; provided, however,
that Company shall not be obligated pursuant to this Section 8(b)(vi) to provide
trade secrets or confidential information or to provide information to any
person whom Company reasonably believes is a competitor, directly or indirectly,
or affiliated with a competitor of Company.

                           (vii) Compliance with Laws. Comply, and cause each
subsidiary to comply, with the requirements of all applicable laws, rules,
regulations and orders of any governmental authority, noncompliance with which
could materially adversely affect its business or condition, financial or
otherwise.

                           (viii) Regulatory Compliance. Comply, and cause each
subsidiary to comply, with all minimum funding requirements applicable to any
pension, employee benefit plans or employee contribution plans which are subject
to the Employee Retirement income Security Act of 1974, as amended ("ERISA"), or
to the Internal Revenue Code of 1986, as amended (the "Code"), and comply, and
cause each subsidiary to comply, in all other material respects with the
provisions of ERISA and the Code, and the rules and regulations thereunder,
which are applicable to any such plan. Neither Company nor any subsidiary will
permit any event or condition to exist which could permit any such plan to be
terminated under circumstances which would cause the

                                       12
<PAGE>

lien provided for in Section 4068 of ERISA to attach to the assets of Company or
any subsidiary.

                           (ix) Maintenance of Accurate Records. Keep, and cause
each subsidiary to keep, adequate records and books of account in which complete
entries will be made in accordance with GAAP consistently applied, reflecting
all financial transactions of Company and any subsidiary, and in which, for each
fiscal year, all proper reserves for depreciation, depletion, returns of
merchandise, obsolescence, amortization, taxes, bad debts and other purposes in
connection with its business shall be made.

                           (x) Financing. Except as otherwise provided in the
Certificate, promptly, fully and in detail, inform the Board of Directors of any
discussions, offers or contracts relating to possible financing or refinancing
of any nature for Company and/or its subsidiaries, whether initiated by Company
or any other person. The Company shall obtain the approval of the Executive
Committee prior to issuing any securities of the Company in connection with bona
fide debt financings, commercial credit arrangements, equipment financings,
leases, technology licenses, strategic alliances, or similar transactions.

                           (xi) Right to Call Board and Stockholder Meetings. At
all times cause its Bylaws to provide that, unless otherwise required by the
laws of the State of Delaware (A) any three directors shall have the right to
call a meeting of the Board of Directors or stockholders and (B) any holder or
holders of at least one third (33.33%) of the outstanding Preferred Stock shall
have the right to call a meeting of the stockholders.

                           (xii) Indemnification of Directors. At all times
maintain provisions in its Bylaws or Certificate of Incorporation, as may be
amended or restated from time to time, indemnifying all directors against
liability, and eliminating all directors' liability for breach of fiduciary
duty, to the maximum extent permitted under the laws of the State of Delaware.

                           (xiii) Election of Officers, Officer Compensation.
All officers of Company must be elected and approved by the Board of Directors.
Officer salaries must be approved by the Executive Committee.

                           (xiv) Investment Bankers and Financial Advisors. All
investment bankers and financial advisors engaged by Company must be approved by
the Board of Directors.

                           (xv) Option Plans and Option Shares. The Board of
Directors of Company shall reserve up to 10,062,500 shares of Common Stock,
subject to adjustment for stock splits, stock dividends and other changes
affecting the Common Stock (collectively, the "Option Shares") for issuance to
Company's directors, officers, employees, advisors and consultants pursuant to
one or more stock option or other equity compensation plans established by
Company (each an "Option Plan") provided that any such Option Plan which shall
be adopted after the date hereof shall be adopted only with

                                       13
<PAGE>

the approval of the Board of Directors, including the approval of the Series B
Director and at least one Series C Director. All grants of Option Shares by
Company to directors, officers, employees, advisors and consultants of Company
made after the date of this Agreement shall be subject to approval of the
Compensation Committee of the Board of Directors. The number of Option Shares
available for issuance may be increased with the approval of the Board of
Directors (including the approval of the Series B Director and one (1) Series C
Director) or the Compensation Committee.

                           (xvi) Transactions with Officers, Directors, and
Subsidiaries. Company may, directly or indirectly, enter into or permit to exist
any transaction with any officer, director, or any affiliate of any of the
foregoing, only upon the approval of a majority of the disinterested directors.

                           (xvii) Key Man Insurance. Company shall maintain or
cause to be maintained, in Company's own name, with financially sound and
reputable insurers, life insurance in an amount not less than One Million
Dollars ($1,000,000) on each of the lives of Jett and Gary A. York ("York"), for
such period of time as each is employed by Company or is an officer or director
of Company. Such policies shall be owned by Company and all benefits thereunder
shall be payable to Company.

                           (xviii) Reservation of Shares. For so long as any
Investor shall have any right to receive shares of Common Stock upon conversion
of the Preferred Stock, the Company shall reserve and keep available out of its
authorized but unissued Common Stock the full number of shares of Common Stock
deliverable upon conversion of all the then outstanding Preferred Stock and
shall, at its own expense, take all such actions and obtain such permits and
orders as may be necessary to enable the Company lawfully to issue such Common
Stock upon conversion of the Preferred Stock.

                           (xix) Use of Proceeds. The proceeds from the sale of
the Series C Preferred shall only be used for working capital and general
corporate purposes.

                           (xx) Fees and Expenses. Company shall reimburse
Investors upon demand for all reasonable costs and expenses (including
reasonable attorneys' fees and expenses) incurred by Investors, or any successor
thereto, in enforcing the obligations of Company under this Agreement, the
Series B Purchase Agreement or the Series C Purchase Agreement.

                           (xxi) Proprietary Information and Invention
Assignment Agreement. The Company will require all future officers and employees
of the Company to execute and deliver a proprietary information and invention
assignment agreement protecting the Company's intellectual property from
misappropriation and disclosure.

         9.       RIGHT OF FIRST PARTICIPATION.

                                       14
<PAGE>

                  (a) GRANT OF PREEMPTIVE RIGHTS. Except as set forth in Section
9(c) hereof, the Company shall not issue or sell any shares of Common Stock, any
rights or options to purchase Common Stock, or any debt or shares convertible
into or exchangeable for Common Stock, whether now or hereafter authorized and
whether unissued or in treasury (collectively, "Preemptive Shares"), unless each
Investor who at such time holds any Preferred Stock (a "Preemptive Investor")
shall first have been given a right to acquire, at a price no less favorable
than that at which such shares, rights, options or obligations are to be offered
to others, a proportion of the offered shares, rights, options or obligations as
provided in Section 9(b). This Section 9 shall not be construed to limit in any
manner any restrictions on the sale of securities of the Company set forth in
the Certificate or elsewhere in this Agreement.

                  (b) METHOD OF EXERCISING PREEMPTIVE RIGHT. The Company shall
give each Preemptive Investor prior written notice of any proposed issuance or
sale described in Section 9(a) and each such Preemptive Investor shall have
twenty (20) days from the giving of such notice within which to elect to acquire
a proportion of the Preemptive Shares being offered equal to such Preemptive
Investor's percentage ownership of the outstanding Common Stock (which shall be
determined as if all outstanding Preferred Stock had been converted into Common
Stock) immediately preceding such issuance or sale ("Initial Preemptive Right").
If any transaction specified by the Company in any such notice shall not be
consummated within six (6) months from the date of such notice, the Company
shall again comply with the provisions of this Section 9(b) with respect to such
transaction, and all Preemptive Investors shall again have preemptive rights
hereunder with respect thereto, regardless of whether any such Preemptive
Investor had previously exercised or failed to exercise such rights. Any
purchase of securities pursuant to the exercise of preemptive rights shall be
consummated simultaneously with, and shall be conditioned upon, consummation of
the transaction proposed by the Company.

                  (c) EXCEPTIONS. The restrictions contained in, and preemptive
rights granted to the Investors under, Sections 9(a) and 9(b) shall not apply to
shares issued or issuable by the Company (i) in connection with a merger or
consolidation of the Company into or with another corporation or a business
combination effected through an exchange of the Company's shares for the
securities or substantially all of the assets of another corporation; (ii) upon
conversion of the Preferred Stock or pursuant to the exercise of stock options
or warrants outstanding on the date of this Agreement; (iii) to an Investor
pursuant to this Section 9; (iv) to persons pursuant to an Option Plan or other
employee benefit plan of the Company; (v) in connection with a dividend or
distribution on Preferred Stock; (vi) in connection with bona fide debt
financings, commercial credit arrangements, equipment financings, leases,
technology licenses, strategic alliances, or similar transactions; (vii) in
connection with bona fide acquisitions, mergers or similar transactions whereby
the Corporation (or the shareholders of the Corporation immediately prior to
such transaction) owns not less than fifty-one percent (51%) of the voting power
of the surviving corporation; (viii) in a public offering prior to or in
connection with which all outstanding shares of each series of Preferred Stock
will be converted into Common Stock; (ix) in connection with other
Board-approved strategic

                                       15
<PAGE>

alliances, customer relationships or commercial lending arrangements; or (x)
shares issued in a Qualifying IPO.

         10. INDICATION OF INTEREST. In the event the Company or the Common
Stockholders receive from a third party an indication of interest (whether
verbal or in writing) in acquiring control of the Company through a purchase of
Company stock, merger, exchange of shares, purchase of substantially all of the
assets of the Company or other similar transaction, the Company and/or the
Common Stockholders shall immediately notify all of the members of the Board of
Directors of such indication of interest.

         11. FORFEITURE OF ISSUED SHARES.

            (a) VESTING OF SHARES. All Shares of the Common Stock (the "Issued
Shares") issued to employees of the Company as of January 10, 2000 shall be
subject to the restrictions and forfeiture provisions set forth in this Section
11 until such time as they become vested as follows: 50% of the Issued Shares
shall have vested on January 10, 2000; an additional 25% of the Issued Shares
shall have vested upon January 10, 2001; and the remaining 25% of the Issued
Shares shall vest on January 10, 2002. Notwithstanding any provision of this
Agreement to the contrary, all Issued Shares shall immediately become fully
vested and not subject to forfeiture under this Section 11 upon the consummation
of a Qualifying IPO by the Company or upon a Liquidation Event. Any Issued
Shares which are vested as of a given point in time are hereinafter referred to
as "Vested Shares" and Issued Shares which are not vested as of a given point in
time are hereinafter referred to as "Non-Vested Issued Shares." If an employee
terminates his employment with the Company for any reason other than the
employee's death or Permanent Disability, or if the Company terminates
employee's employment for Just Cause (in each instance, a "Forfeiture Event"),
the employee shall forfeit and have no further right to any Non-Vested Issued
Shares at the date of termination and shall transfer and assign the same to the
Company for a purchase price equal to the book value of such Non-Vested Issued
Shares, as shown on the books and records of the Company assuming that all
outstanding shares of Preferred Stock were converted into shares of Common Stock
on a one-for-one basis (the "Purchase Price"), as of the end of the month
preceding the employee's termination, such amount to be paid in cash within
thirty (30) days following the effective date of such termination of employment.
Promptly following a Forfeiture Event, the employee shall deliver to the Company
the certificate evidencing the Non-Vested Issued Shares, and the Company shall
deliver to the employee a new certificate evidencing any Issued Shares which
have not been forfeited and which are also represented by such certificate,
together with the Purchase Price. Subject to the provisions hereof, the employee
shall be the owner of the Issued Shares and shall possess all voting rights,
dividend rights and other rights incident to such ownership until the ownership
thereof is forfeited as provided herein. For purposes of this Agreement, the
term "Permanent Disability" shall mean the incapacity or inability of the
employee to perform all of his duties and obligations pursuant to his
employment, due to illness or accident (excluding infrequent and temporary
absences due to ordinary illnesses), which may be reasonably expected to exist
for more than one hundred eighty (180) days. For

                                       16
<PAGE>

purposes of this Agreement, a "Liquidation Event" means (i) any consolidation or
merger of the Company with or into any other corporation or other entity or
person, or any other corporate reorganization, in which the stockholders of the
Company immediately prior to such consolidation, merger or reorganization own
less than 50% of the surviving entity's voting power immediately after such
consolidation, merger or reorganization, or any transaction or series of related
transactions in which more than fifty percent (50%) of the Company's voting
power is transferred to a party or group of affiliated parties; or (ii) a sale,
lease or other disposition of all or substantially all of the assets of the
Company. For further purposes of this Agreement, the term "Just Cause" shall
mean the employee's (A) failure to follow lawful directions from the Company's
President or Board of Directors, (B) conduct disloyal to the Company or breach
of any fiduciary duty to the Company including the usurpation of any business
opportunity of the Company, (C) proven dishonesty, theft, fraud or embezzlement,
(D) conviction of a felony or a crime involving moral turpitude, (E) substantial
dependence on or addiction to alcohol or drugs, except for drugs legally used
pursuant to the direction of a licensed medical doctor, or (F) breach of any
material provision of this Agreement or neglect of the proper performance of his
duties if, during the ten (10) day period following the employee's receipt of
written notice from the Company describing such breach or neglect in reasonable
detail, the employee does not promptly commence in good faith to cure such
breach or neglect; provided, however, that such cure must be effected no later
than thirty (30) days following such notice; and provided, further, that such
cure right shall not be available to employee on more than one (1) occasion in
any twelve (12) month period.

         (b) OPTION TO PURCHASE VESTED SHARES UPON TERMINATION OF EMPLOYMENT. If
an employee who was an employee of the Company on January 10, 2000 is terminated
for any reason, the Company shall have the option, but not the obligation,
exercisable by written notice given within sixty (60) days after the effective
date of such employee's termination, to purchase all of the employee's Vested
Shares for a purchase price equal to the purchase price paid by any stockholder
for such stockholder's Shares (whether preferred or common) if the Company has
issued such stockholder's Shares within one hundred eighty (180) days prior to
the effective date of the employee's termination. If the Company has not issued
any Shares within such one hundred eighty (180) days, the Company may purchase
such terminated employee's Vested Shares for a purchase price equal to the last
purchase price paid by any other stockholder for such stockholder's Shares plus
the additional sum of ten percent (10%) of such purchase price per calendar
quarter since the issuance of such Shares by the Company. If the Company
exercises its option pursuant to this Section 11(b), the Company, in its sole
discretion, may pay the purchase price of the Vested Shares to the terminated
employee (i) in cash upon closing, or (ii) by delivering to the terminated
employee a promissory note executed by the Company in favor of such employee
representing the purchase price therefor, and requiring quarterly payments of
principal and interest for a term of three (3) years (such interest to accrue at
the prime rate in effect upon the date of such employee's termination).
Notwithstanding any provision hereof, the provisions of this Section 11(b) shall
terminate on the earlier of January 10, 2002 or the date of Qualifying IPO.

                                       17
<PAGE>

         12. PATENTS AND TRADEMARKS. Each Common Stockholder agrees and
acknowledges that such Common Stockholder has no right to or interest in, and
hereby disclaims any right to or interest in, any inventions, improvements,
discoveries or other information (whether tangible or intangible) utilized by
the Company in its business as conducted or proposed to be conducted
("Proprietary Information"). Notwithstanding the preceding sentence, and in
furtherance thereof, each Common Stockholder hereby assigns to the Company all
of such Common Stockholder's right, title and interest in and to such
Proprietary Information that the Common Stockholder has heretofore or may in the
future conceive, reduce to practice or otherwise create (either alone or jointly
with others) in the course of his employment by the Company or any affiliate of
the Company. Upon request by the Company, the Common Stockholder shall execute
and deliver to the Company, without further compensation, any and all documents
that the Company deems necessary or appropriate to (a) prepare or prosecute
applications for patents or copyrights upon such Proprietary Information, (b)
assign and transfer to the Company his entire right, title and interest in and
to such Proprietary Information and patents or copyrights therefor and (c)
evidence more fully and perfectly the Company's ownership thereof.

         13. TERMINATION. This Agreement shall remain in full force and effect
until the closing of the sale of shares of Company's Common Stock by Company in
a Qualifying IPO.

         14. CONVERSION OF SHARES OF SERIES B PREFERRED. The parties agree and
acknowledge that certain Investors, identified on Schedule 4 herein, have agreed
that the Shares of Series B Preferred previously held by them would be
reclassified as, and automatically converted into an equivalent number of shares
of Series B-1 Preferred effective upon and concurrently with the filing of the
Certificate with the State of Delaware Division of Corporations and the Shares
held by such Investors shall be deemed for all purposes to be Shares of Series
B-1 Preferred, and not Shares of Series B Preferred, from and after the date of
this Agreement. The holder of any Shares of Series B Preferred converted
pursuant to this Section 14 shall promptly deliver to the Secretary of the
Company at the address set forth in Section 15(d) hereof the certificate or
certificates for the Shares so converted, duly endorsed or assigned in blank to
the Company. As promptly as practicable thereafter, the Company shall issue and
deliver to such holder, at the place designated by such holder, a certificate or
certificates for the number of Shares of Series B-1 Preferred to be issued.

         15.      GENERAL PROVISIONS.

                  (a) AUTHORIZATION. Each Common Stockholder and Investor hereby
represents and warrants to the Company and to each other that (i) such Common
Stockholder or Investor has full power and authority to execute, to deliver and
to perform such Common Stockholder's or Investor's obligations under this
Agreement; and (ii) the execution and delivery of this Agreement has been duly
and validly authorized, and all necessary action has been taken to make this
Agreement a valid and binding obligation of such Common Stockholder or Investor,
enforceable in accordance with its terms, except that the enforcement thereof
may be subject to bankruptcy, insolvency, reorganization,

                                       18
<PAGE>

moratorium or other similar laws now or hereafter in effect relating to
creditors' rights generally and to general principles of equity (regardless of
whether such enforcement is considered a proceeding in equity or at law).

                  (b) AFTER-ACQUIRED SHARES. All of the provisions of this
Agreement shall apply to (i) all of the Shares now owned or which may be
subsequently transferred to, or owned by, any Common Stockholder or Investor and
(ii) all securities and instruments (A) received by a Common Stockholder or
Investor as a dividend on, or other payment made to holders of, shares of
capital stock of the Company, or (B) issued in connection with a split of shares
of capital stock of the Company, or as a result of any exchange for or
reclassification of shares of capital stock of the Company, or a reorganization,
recapitalization, consolidation or merger. In addition, any person or entity who
does not presently own but subsequently acquires newly-issued shares or
securities convertible into or exercisable or exchangeable for shares of the
capital stock of the Company shall become a party to and be bound by this
Agreement as a condition to the Company's issuance of such shares to such person
or entity.

                  (c) RIGHTS AND OBLIGATIONS OF TRANSFEREES. If a Common
Stockholder or Investor transfers any or all of its Shares to any person, such
person and each subsequent transferee shall have the same rights hereunder as
are given to such Common Stockholder or Investor, and shall be subject to the
same obligations as are imposed upon such Common Stockholder or Investor by the
terms hereof (and all references herein to a Common Stockholder or Investor (as
applicable) shall include such transferee), unless otherwise provided herein.
Any such transferee shall execute and deliver to the Investors, Common
Stockholders and the Company a counterpart to this Agreement acknowledging such
transferee's agreement to be bound by the terms of this Agreement. The Company
will not record any transfer of Shares made in violation of any provision of
this Agreement.

                  (d) NOTICES. All notices and other communications required or
permitted hereunder shall be in writing and shall be deemed effectively given
upon personal delivery, confirmed delivery by facsimile or telecopy, delivery by
recognized overnight courier (such as Federal Express), or on the fifth day (or
the tenth day if to a party with a foreign address) following mailing by
registered or certified mail, return receipt requested, postage prepaid,
addressed: (i) if to a Common Stockholder, at such Common Stockholder's address
as set forth on Schedule 1 attached hereto, or at such other address as such
Common Stockholder shall have furnished to the other parties hereto in writing;
(ii) if to a Series A Investor, at such Series A Investor's address as set forth
on Schedule 2 attached hereto, or at such other address as such Series A
Investor shall have furnished to the other parties hereto in writing; (iii) if
to a Series B Investor or Series B-1 Investor, at such Series B Investor's or
Series B-1 Investor's address as set forth on Schedule 3 (or Schedule 4)
attached hereto, or at such other address as such Series B Investor or Series
B-1 Investor shall have furnished to the other parties hereto in writing; (iv)
if to a Series C Investor, at such Series C Investor's address as set forth on
Schedule 5 attached hereto, or at such other address as such Series C Investor
shall have furnished to the other parties hereto in writing, with a copy to:

                                       19
<PAGE>

                  John R. Wynn, Esquire
                  Lanier Ford Shaver & Payne, P.C.
                  P.O. Box 2087
                  Huntsville, Alabama  35804
                  Telephone:  (256) 535-1100
                  Facsimile:  (256) 535-1135

                  (v) if to Company, at the address noted below, or at such
other address as Company shall have furnished to the other parties hereto in
writing:

                  Emageon, Inc.
                  Attention:  Charles A. Jett, Jr.
                  1200 Corporate Drive
                  Suite 400
                  Birmingham, Alabama 35242
                  Telephone:  (205) 980-7610
                  Facsimile:  (205) 980-9815

with a copy to:

                  Martin R. Tilson, Jr., Esquire
                  Kilpatrick Stockton LLP
                  Suite 2800
                  1100 Peachtree Street
                  Atlanta, Georgia 30309
                  Telephone:  (404) 815-6565
                  Facsimile:  (404) 815-6555

                  (e) AMENDMENT AND WAIVER. Except as otherwise expressly
provided herein, any term of this Agreement may be amended and the observance of
any term of this Agreement may be waived (either generally or in a particular
instance, either retroactively or prospectively, and either for a specified
period of time or indefinitely) with the written consent of (i) the Company,
(ii) the Investors (or their transferees) holding a majority of the outstanding
shares of Preferred Stock (voting together as a single class) and (iii) the
Common Stockholders (or their transferees) holding a majority of the outstanding
shares of Common Stock. Any amendment or waiver effected in accordance with this
Section 15(e) shall be binding upon Company, Common Stockholders, and Investors
and each of their future transferees. Upon the effectuation of each such
amendment or waiver, Company shall promptly give written notice thereof to the
holders of the Shares who have not previously consented thereto in writing.
Notwithstanding anything to the contrary in this Section 14(e), the Company
shall be entitled to add additional purchasers of shares of its Preferred Stock
pursuant to Section 2.1 of the Series C Preferred Stock Purchase Agreement of
even date herewith as parties to this Agreement as and in the manner set forth
in such Section 2.1, and each such

                                       20
<PAGE>

additional purchaser shall thereafter be deemed to be a Series C Investor for
all purposes hereunder.

                  (f) GOVERNING LAW. This Agreement shall be governed by and
construed under the laws of the State of Delaware, as applied to agreements
among Delaware residents made and to be performed entirely within the State of
Delaware, and without regard to the conflicts of law principles as may otherwise
be applicable.

                  (g) JURISDICTION AND VENUE. Each party to this Agreement
hereby irrevocably agrees that any legal action or proceeding arising out of or
relating to this Agreement or the transactions contemplated hereunder may be
brought in the courts of Shelby County in the State of Alabama or of the United
States of America for the Northern District of Alabama, and hereby expressly
submits to the personal jurisdiction and venue of such courts for the purposes
thereof and expressly waives any claim of improper venue and any claim that such
courts are an inconvenient forum. Each party hereby irrevocably consents to the
service of process of any of the aforementioned courts in any such suit, action
or proceeding, by the mailing of copies thereof by registered or certified mail,
postage prepaid, to its address set forth in this Agreement, such service to
become effective ten (10) days after such mailing.

                  (h) BINDING ON SUCCESSORS. This Agreement shall bind and inure
to the benefit of the parties hereto, their respective heirs, executors,
administrators, successors and permitted assigns, including any transferees
permitted under Sections 1 or 2 hereof.

                  (i) COUNTERPARTS AND SIGNATURE BY FACSIMILE. This Agreement
may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same
instrument. The facsimile signature of any party to this Agreement for purposes
of execution or otherwise is to be considered as an original signature, and the
document transmitted is to be considered to have the same binding effect as an
original signature on an original document. At the request of any party, any
facsimile or telecopy document is to be re-executed in original form by the
parties who executed the facsimile or telecopy document. No party may raise the
use of a facsimile machine or telecopier or the fact that any signature was
transmitted through the use of a facsimile or telecopier machine as a defense to
the enforcement of this Agreement or any notice required thereof.

                  (j) ENTIRE AGREEMENT. This instrument shall constitute the
entire understanding between the parties, superseding any and all previous
understandings, oral or written, pertaining to the subject matter contained
herein, including without limitation, the Series A Agreement, Series B
Agreement, the Common Agreement and the Investor Rights Agreement. In connection
therewith, each of the Investors and each of the Common Stockholders agree that
the Series A Agreement, the Series B Agreement, Common Agreement and Investor
Rights Agreement are hereby terminated and shall have no further force and
effect. Each of the Investors and each of the Common

                                       21
<PAGE>

Stockholders further waive any and all rights they may have under such Series A
Agreement, Series B Agreement, Common Agreement and Investor Rights Agreement.

                  (k) JOINDER OF ADDITIONAL COMMON STOCKHOLDERS. Company agrees
to use commercially reasonable efforts to cause each person or entity that
hereafter becomes a holder of 5% or more of the outstanding shares of Common
Stock of the Company to execute and deliver to Company a counterpart of this
Agreement as a condition to the Company's issuing such shares. Upon such
execution and delivery, copies of such counterparts shall be delivered by
Company to Common Stockholders and Investors.

                   [THE FOLLOWING PAGE IS THE SIGNATURE PAGE]

                                       22
<PAGE>

                               SIGNATURE PAGE FOR
                                  EMAGEON, INC.

         IN WITNESS WHEREOF, the parties have executed this Agreement under seal
as of the day and year first above written, the corporate parties acting by
their duly authorized officers.

                                            COMPANY:

                                            EMAGEON, INC.

                                            By: /s/ Charles A. Jett, Jr.
                                                --------------------------------
                                                Charles A. Jett, Jr., President

ATTEST:

/s/ Donald A. Ulinski
------------------------------------
Donald A. Ulinski, Secretary

[Corporate Seal]

                                       23
<PAGE>

[Individual Signature Pages of Parties Identified on Attached Schedules Omitted]

                                       24
<PAGE>

                                   SCHEDULE 1

                               COMMON STOCKHOLDERS

NAME AND ADDRESS

Charles A. Jett, Jr.
608 Queen's Gate
Birmingham, AL  35242
Facsimile: (205) 980-9815

Gary A.York
2158 Baneberry Drive
Birmingham, AL  35244
Facsimile: (205) 980-9815

Barton Guthrie
2423 Fairway Drive
Birmingham, AL,  35213
Facsimile: (205) 975-6088

Joseph Wortmann
800 Country Road 133
Calera, AL  35040
Facsimile: (205) 980-9815

Marc Guthrie
3621 Robin Circle
Birmingham, AL  35242
Facsimile: (205) 980-9815

Russell H. Maddox
3899 Lockerbie Drive
Mountain Brook, AL  35223
Facsimile:

Jeff Timbrook
7006 North Highfield Drive
Birmingham, AL  35242
Facsimile: (205) 980-9815

<PAGE>

UAB Research Foundation
Attn: Dr. Lee Martin
AB 1120G
1530 3rd Ave. South
Birmingham, AL  35294
Facsimile: (205) 975-5560

Scott Pechman
1047 Oak Meadows Road
Birmingham, AL  35242
Facsimile: (205) 991-5321

Allen Scales
1007 Watermill Circle
Birmingham, AL  35242
Facsimile: (205) 980-9815

Timothy Blackmon
1404 Oakwood Drive
Birmingham, AL  35007
Facsimile:

Razvan Atanasiu
3708 Buck Horn Cove
Birmingham, AL  35242
Facsimile: (205) 980-9815

Russell Allen
149 Camden Lake Drive
Calera, AL  35040
Facsimile: (205) 980-9815

Jean Francois Bertrand
89 Winterhaven Drive
Birmingham, AL  35007
Facsimile:

<PAGE>

                                   SCHEDULE 2

                               SERIES A INVESTORS

NAME AND ADDRESS

Finn Partners, LLC
Attn: Jouko Rissenan
2660 Peachtree Road, NW #34G
Atlanta, GA  30305
Facsimile: (404) 841-6293

Russell H. Maddox
3899 Lockerbie Drive
Mountain Brook, AL  35223
Facsimile:

Benson McLendon and Joan G. McLendon
Tenants in Common
Attn: Benson R. McLendon
104 Inverness Center, Suite 100
Birmingham, AL  35242
Facsimile: (205) 991-5373

Joan G. McLendon TTEE Benson R. McLendon, Jr.
Children's Trust U/A Dtd.
12/20/95 FBO Amy Elizabeth McLendon
Attn: Benson R. McLendon
104 Inverness Center, Suite 100
Birmingham, AL  35242
Facsimile: (205) 991-5373

Stephen L. Barnett
123 Cook Street
Denver, CO  80206
Facsimile: (303) 377-0632

Frist Family Internet Partners
Attn: Dr. Robert Frist
1326 Page Road
Nashville, TN  37205
Facsimile: (615) 298-2492

<PAGE>

John P. Hamilton
23 Winthrop Avenue
Birmingham, AL  35213
Facsimile:

Hugh H. Williamson III Revocable Trust
Attn: Hugh H. Williamson III
123 Cook Street
Denver, CO  80206
Facsimile: (303) 377-0632

Charles A. Jett, Jr.
608 Queen's Gate
Birmingham, AL  35242
Facsimile: (205) 980-9815

Paradigm Venture Partners, L.P.
Attn: Roddy Clark
500 Beacon Parkway West
Birmingham, AL  35209
Facsimile: (205) 943-8565

<PAGE>

                                   SCHEDULE 3

                               SERIES B INVESTORS

STF Institutional Partners II, L.P.
Attn: Chris H. Horgen
207 East Side Square
Huntsville, Alabama 35801
Facsimile: (256) 883-8558

STF Partners QP II, L.P.
Attn: Chris H. Horgen
207 East Side Square
Huntsville, Alabama 35801
Facsimile: (256) 883-8558

STF Partners II, L.P.
Attn: Chris H. Horgen
207 East Side Square
Huntsville, Alabama 35801
Facsimile: (256) 883-8558

Harbinger/Aurora Venture Fund, L.L.C.
Attn: William Brooke
One Riverchase Parkway South
Birmingham, Alabama 35203
Facsimile: (205) 987-5505

Harbinger/Aurora QP Venture Fund, L.L.C.
Attn: William Brooke
One Riverchase Parkway South
Birmingham, Alabama 35203
Facsimile: (205) 987-5505

Jemison Investment Co., Inc.
Attn: James D. Davis
2001 Park Place, Suite 320
Birmingham, Alabama 35203
Facsimile: (205) 324-7684

James D. Davis
2001 Park Place, Suite 320
Birmingham, Alabama 35203
Facsimile: (205) 324-7684

<PAGE>

Richgood Corporation
Attn: Bill Goodrich
402 Office Park Dr., Suite 104
Birmingham, Alabama 35223
Facsimile: (205) 879-3337

Horgen One Investment, L.L.C.
Attn: Chris H. Horgen
207 East Side Square
Huntsville, Alabama 35801
Facsimile: (256) 883-8558

Southeastern Technology Fund, L.P.
Attn: Chris H. Horgen
207 East Side Square
Huntsville, Alabama 35801
Facsimile: (256) 883-8558

Paradigm Venture Partners, L.P.
Attn: Roddy Clark
500 Beacon Parkway, West
Birmingham, Alabama 35209
Facsimile: (205) 943-8565

Greystone Capital Partners I, L.L.C.
Attn: Alex B. Leath, III
1710 6th Avenue North
Birmingham, Alabama 35203
Facsimile: (205) 226-8799

Paul Reaves
2816 Berkeley Drive
Birmingham, AL  35242
Facsimile: (205) 408-7037

<PAGE>

                                   SCHEDULE 4

                              SERIES B-1 INVESTORS

Ropar, Ltd.
Attn: Daniel Roberts
4233 Caldwell Mill Road
Birmingham, AL  35243
Facsimile: (205) 968-0210

Robtel, Inc.
Attn: Daniel Roberts
4233 Caldwell Mill Road
Birmingham, AL  35243
Facsimile: (205) 968-0210

MMM Emageon, L.L.C.
Attn: Charles Beaudrot
1600 Atlanta Financial Center
3343 Peachtree Road, N.E.
Atlanta, Georgia 30326
Facsimile: (404) 365-9532

Benson R. McClendon
104 Inverness Center, Suite 100
Birmingham, Alabama 35242
Facsimile: (205) 991-5373

The Permanente Federation LLC
Attn: Chris Stenzel
1800 Harrison Street, 22nd Floor
Oakland, CA  94612
Facsimile: (510) 267-4036

Kaiser Foundation Hospitals
Attn: Chris Stenzel
1800 Harrison Street, 22nd Floor
Oakland, CA  94612
Facsimile: (510) 267-4036

T.I. EMA Inc.
Attn: Brandon Edwards
3820 State Street
Santa Barbara, CA  93105
Facsimile: (805) 563-7146

<PAGE>

                                   SCHEDULE 5

                               SERIES C INVESTORS

STF Institutional Partners II, L.P.
Attn: Chris H. Horgen
207 East Side Square
Huntsville, Alabama 35801
Facsimile: (256) 883-8558

STF Partners QP II, L.P.
Attn: Chris H. Horgen
207 East Side Square
Huntsville, Alabama 35801
Facsimile: (256) 883-8558

STF Partners II, L.P.
Attn: Chris H. Horgen
207 East Side Square
Huntsville, Alabama 35801
Facsimile: (256) 883-8558

Harbinger/Aurora Venture Fund, L.L.C.
Attn: William Brooke
One Riverchase Parkway South
Birmingham, Alabama 35203
Facsimile: (205) 987-5505

Harbinger/Aurora QP Venture Fund, L.L.C.
Attn: William Brooke
One Riverchase Parkway South
Birmingham, Alabama 35203
Facsimile: (205) 987-5505

Jemison Investment Co., Inc.
Attn: James D. Davis
2001 Park Place, Suite 320
Birmingham, Alabama 35203
Facsimile: (205) 324-7684

James D. Davis
2001 Park Place, Suite 320
Birmingham, Alabama 35203
Facsimile: (205) 324-7684

<PAGE>

Richgood Corporation
Attn: Bill Goodrich
402 Office Park Dr., Suite 104
Birmingham, Alabama 35223
Facsimile: (205) 879-3337

Paradigm Venture Partners, L.P.
Attn: Roddy Clark
500 Beacon Parkway West
Birmingham, AL  35209
Facsimile: (205) 943-8565

Greystone Capital Partners I, L.L.C.
Attn: Alex B. Leath, III
1710 6th Avenue North
Birmingham, Alabama 35203
Facsimile: (205) 226-8799

Miller Investment, LLC
Attn: Larry Waldrep
P.O. Box 957
Brewton, AL  36427
Facsimile: (251) 867-2146

William D. Melton
100 Liberty Hill Drive
P.O. Box 800
Evergreen, AL  36401
Facsimile: (251) 578-2427

MEI Holdings, LLC
Attn: Roy B. York
10625 Puckett Road
Perry, FL  32347
Facsimile: (850) 584-2044

Delta Venture Partners I, L.P.
Attn: Donald L. Mundie, Chief Manager,
         Venture Partners I, LLC
8000 Centerview Parkway, Suite 100
Cordova, TN  38018
Facsimile: (901) 755 0436

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}]]